Document:

Form of Indemnification Agreement

 Exhibit 10.20.1 
 UNIFIED WESTERN GROCERS, INC. 
 INDEMNIFICATION AGREEMENT 
 This Indemnification Agreement (“Agreement”) is made as of
                     by and between UNIFIED WESTERN GROCERS, INC., a California corporation (the “Company”), and
                     (“Indemnitee”). 
 RECITALS 
 A. The Company believes that it is essential to its best interest to attract and retain
highly capable persons to serve as directors, officers and other agents of the Company. 
 B. The Company and Indemnitee recognize the
increased risk of litigation and other claims being asserted against directors, officers and other agents of corporations. 
 C. In
recognition of the need for substantial protection against personal liability to attract and retain the services of qualified individuals, such as Indemnitee, to serve as directors, officers and other agents of the Company and to induce Indemnitee
to provide or continue to provide services to the Company as a director, officer or other agent, the Company wishes to provide in this Agreement for the indemnification of and the advancement of expenses to Indemnitee to the fullest extent permitted
by law and as set forth in this Agreement. 
 IN CONSIDERATION of the foregoing and of Indemnitee’s providing or continuing to provide
services to the Company directly or at its request with another enterprise, the parties agree as follows: 
 1. Indemnification.

 (a) Third Party Proceedings. The Company shall indemnify Indemnitee if Indemnitee is or was a party or is threatened to be made a
party to any threatened, pending or completed action or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the Company) (i) by reason of the fact that Indemnitee is or was a
director, officer, employee or agent of the Company, or any subsidiary of the Company, or (ii) by reason of the fact that Indemnitee is or was serving at the request of the Company as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement (but only if such settlement is approved in advance by the Company) actually and
reasonably incurred by Indemnitee in connection with such action or proceeding if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in the best interests of the Company, and, with respect to any criminal action or
proceeding, had no reasonable cause to believe Indemnitee’s conduct was unlawful. The termination of any action or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of
itself, create a presumption that (i) Indemnitee did not act in good faith, (ii) Indemnitee did not act in a manner which Indemnitee reasonably believed to be in the best interests of the Company, or (iii) with respect to any criminal
action or proceeding, Indemnitee had no reasonable cause to believe that Indemnitee’s conduct was unlawful. 
  

 -1- 

 (b) Proceedings By or in the Right of the Company. To the fullest extent permitted by law,
the Company shall indemnify Indemnitee if Indemnitee was or is a party or is threatened to be made a party to any threatened, pending or completed action or proceeding by or in the right of the Company or any subsidiary of the Company to procure a
judgment in its favor (i) by reason of the fact that Indemnitee is or was a director, officer, employee or agent of the Company, or any subsidiary of the Company, or (ii) by reason of the fact that Indemnitee is or was serving at the
request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees) and, amounts paid in settlement, in each case to the
extent actually and reasonably incurred by Indemnitee in connection with the defense or settlement of such action or proceeding if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in the best interests of the
Company and its shareholders, except that no indemnification shall be made in respect of any claim, issue or matter as to which Indemnitee shall have been adjudged to be liable to the Company in the performance of Indemnitee’s duty to the
Company and its shareholders unless and only to the extent that the court in which such action or proceeding is or was pending shall determine upon application that, in view of all the circumstances of the case, Indemnitee is fairly and reasonably
entitled to indemnity for expenses and then only to the extent that the court shall determine. 
 2. Indemnification Procedure and
Determination. 
 (a) Advancement of Expenses. The Company shall advance all expenses incurred by Indemnitee in connection with the
investigation, defense, settlement or appeal of any civil or criminal action or proceeding referenced in Section 1(a) or (b) hereof (but not amounts actually paid in settlement of any such action or proceeding). Indemnitee hereby
undertakes to repay such amounts advanced only if, and to the extent that, it shall ultimately be determined that Indemnitee is not entitled to be indemnified by the Company as authorized hereby. The advances to be made hereunder shall be paid by
the Company to Indemnitee within twenty (20) days following delivery of a written request (together with the copies of invoices presented to Indemnitee for such expenses) therefor by Indemnitee to the Company. 
 (b) Notice and Cooperation by Indemnitee. Indemnitee shall, as a condition precedent to his right to be indemnified under this Agreement, give the
Company notice in writing as soon as practicable of any claim made against Indemnitee for which indemnification will or could be sought under this Agreement. Notice to the Company shall be directed to the Chief Executive Officer of the Company at
the address shown on the signature page of this Agreement (or such other address as the Company shall designate in writing to Indemnitee). Notice shall be deemed received three business days after the date postmarked if sent by domestic certified or
registered mail, properly addressed; otherwise notice shall be deemed received when such notice shall actually be received by the Company. In addition, Indemnitee shall give the Company such information and cooperation as it may reasonably require
and as shall be within lndemnitee’s power. The Chief Executive Officer of the Company shall, promptly upon receipt of any such request for indemnification, advise the Board of Directors of the Company in writing that Indemnitee has requested
indemnification. 
  

 -2- 

 (c) Determination of Right to Indemnity. Upon receipt of a written request by Indemnitee for
indemnification pursuant to Section 2(b), the Company shall determine by any of the methods set forth in Section 317 of the California General Corporation Law whether Indemnitee has met the applicable standards of conduct which make it
permissible under applicable law to indemnify Indemnitee. Any indemnification provided for in Section 2 shall be made no later than forty-five (45) days after receipt of the written request of Indemnitee. If a claim under this Agreement,
under any statute, or under any provision of the Company’s Articles of Incorporation or Bylaws providing for indemnification, is not paid in full by the Company within forty-five (45) days after a written request for payment thereof has
first been received by the Company, Indemnitee may, but need not, at any time thereafter bring an action against the Company to recover the unpaid amount of the claim and, subject to Section 13 of this Agreement, Indemnitee shall also be
entitled to be paid for the expenses (including attorneys’ fees) reasonably incurred of bringing such action. It shall be a defense to any such action (other than an action brought to enforce a claim for expenses incurred in connection with any
action or proceeding in advance of its final disposition) that Indemnitee has not met the standards of conduct which make it permissible under applicable law for the Company to indemnify Indemnitee for the amount claimed, but the burden of proving
such defense shall be on the Company, and Indemnitee shall be entitled to receive interim payments of expenses pursuant to Subsection 2(a) unless and until such defense may be finally adjudicated by court order or judgment from which no further
right of appeal exists. 
 It is the parties’ intention that if the Company contests Indemnitee’s right to indemnification, the question of
Indemnitee’s right to indemnification shall be for the court to decide, and neither the failure of the Company (including its Board of Directors, any committee or subgroup of the Board of Directors, independent legal counsel, or its
shareholders) to have made a determination that indemnification of Indemnitee is proper in the circumstances because Indemnitee has met the applicable standard of conduct required by applicable law, nor an actual determination by the Company
(including its Board of Directors, any committee or subgroup of the Board of Directors, independent legal counsel, or its shareholders) that Indemnitee has not met such applicable standard of conduct, shall create a presumption that Indemnitee has
or has not met the applicable standard of conduct. 
 (d) Notice to Insurers. If, at the time of the receipt of a notice of a claim
pursuant to Section 2(b) hereof, be Company has director and officer liability insurance in effect; the Company shall give prompt notice of the commencement of such proceeding to the insurers in accordance with the procedures set forth in the
respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such proceeding in accordance with the terms of such policies.
The obligation of the Company to indemnify the Indemnitee under this Agreement shall be secondary, and all applicable director and officer liability insurance shall be primary. 
 (e) Selection of Counsel. In the event the Company shall be obligated under any provision of this Agreement to indemnify Indemnitee or to pay the
expenses of any proceeding against Indemnitee, the Company, if appropriate, shall be entitled to assume the defense of such proceeding, with counsel approved by Indemnitee, which approval shall not be unreasonably withheld, upon the delivery to
Indemnitee of written notice of its election so to do. After delivery of such notice, approval of such counsel by Indemnitee and the retention of such counsel by the Company, the Company will not be liable to Indemnitee under this Agreement for

  

 -3- 

 any fees of counsel subsequently incurred by Indemnitee with respect to the same proceeding, provided that
(i) Indemnitee shall have the right to employ his counsel in any such proceeding at Indemnitee’s expense; and (ii) if (A) the employment of counsel by Indemnitee has been previously authorized in writing by the Company,
(B) Indemnitee shall have reasonably concluded that there may be a conflict of interest between the Company and Indemnitee in the conduct of any such defense or (C) the Company shall not, in fact, have employed counsel to assume the
defense of such proceeding, then the reasonable fees and expenses of Indemnitee counsel shall be at the expense of the Company. 
 (f)
Mandatory Payment of Expenses. To the extent that Indemnitee has been successful on the merits, in defense of any action or proceeding referred to in Section 1 of this Agreement or in defense of any claim, issue or matter therein,
Indemnitee shall be indemnified against expenses actually and reasonably incurred by Indemnitee in connection therewith. 
 3. Additional
Indemnification Rights; Nonexclusivity. 
 (a) Scope. Notwithstanding any other provision of this Agreement, the Company hereby
agrees to indemnify the Indemnitee for acts, omissions or transactions while acting in the capacity of, or in the course of serving as, a director, officer or other agent of the Company or any subsidiary of the Company, or as a director, officer or
other agent of another corporation, partnership, joint venture, trust or other enterprise if Indemnitee is or was serving at the request of the Company, to the fullest extent permitted by law, notwithstanding that such indemnification is not
specifically authorized by the other provisions of this Agreement, the Company’s Articles of Incorporation, the Company’s Bylaws or by statute. In the event of any change, after the date of this Agreement, in any applicable law, statute or
rule which expands the right of a California corporation to indemnify a member of its board of directors, an officer or other agent, such changes shall be, ipso facto, within the purview of Indemnitee’s rights and Company’s
obligations, under this Agreement. In the event of any change in any applicable law, statute or rule which narrows the right of a California corporation to indemnify a member of its Board of Directors, an officer or other agent, such changes, to the
extent not otherwise required by such law, statute or rule to be applied to this Agreement shall have no effect on this Agreement or the parties’ rights and obligations hereunder. 
 (b) Nonexclusivity. The indemnification provided by this Agreement shall not be deemed exclusive of any rights to which Indemnitee may be entitled
under the Company’s Articles of Incorporation, its Bylaws, any agreement, any vote of shareholders or disinterested directors, the General Corporation Law of the State of California, or otherwise, both as to action in Indemnitee’s official
capacity and as to action in another capacity while holding such office. The indemnification provided under this Agreement shall continue as to Indemnitee for any action taken or not taken while serving in an indemnified capacity even though he may
have ceased to serve in such capacity at the time of any action or other covered proceeding. 
 4. Partial Indemnification. If
Indemnitee is entitled under any provision of this Agreement to indemnification or advancement by the Company for some or a portion of the expenses, judgments, fines or penalties actually or reasonably incurred by him in the investigation, defense,
appeal or settlement of any civil or criminal action or proceeding, but not, however, for the total amount thereof, the Company shall nevertheless indemnify or pay advancements to Indemnitee for the portion of such expenses, judgments, fines or
penalties to which Indemnitee is entitled. 
  

 -4- 

 5. Mutual Acknowledgement. Both the Company and Indemnitee acknowledge that in certain instances,
Federal law or applicable public policy may prohibit the Company from indemnifying its directors and officers under this Agreement or otherwise. Indemnitee understands and acknowledges that the Company has undertaken or may be required in the future
to undertake with the Securities and Exchange Commission to submit the question of indemnification to a court in certain circumstances for a determination of the Company’s right under public policy to indemnify Indemnitee. 
 6. Directors’ and Officers’ Liability Insurance. The Company in its discretion may, from time to time, purchase and maintain insurance
on behalf of any person who is a director, officer, employee or other agent against any liability asserted against such person and incurred by him in such capacity or arising out of his status as such, whether or not the Company would be required to
indemnify such person against such liability under the provisions of this Agreement. 
 7. Severability. Nothing in this Agreement is
intended to require or shall be construed as requiring the Company to do or fail to do any act in violation of applicable law. The Company’s inability, pursuant to court order, to perform its obligations under this Agreement shall not
constitute a breach of this Agreement. The provisions of this Agreement shall be severable as provided in this Section 7. If this Agreement or any portion hereof shall be invalidated on any ground by any court of competent jurisdiction, then
the Company shall nevertheless indemnify Indemnitee to the full extent permitted by any applicable portion of this Agreement that shall not have been invalidated, and the balance of this Agreement not so invalidated shall be enforceable in
accordance with its terms. 
 8. Exceptions. Any other provision herein to the contrary notwithstanding, the Company shall not be
obligated pursuant to the terms of this Agreement: 
 (a) Excluded Acts. To indemnify Indemnitee for any acts or omissions or
transactions from which a director may not be relieved of liability under the California General Corporation Law. 
 (b) Claims Initiated
by Indemnitee. To indemnify or advance expenses to Indemnitee with respect to proceedings or claims initiated or brought voluntarily by Indemnitee and not by way of defense, except with respect to proceedings brought to establish or enforce a
right to indemnification under this Agreement or any other statute or law or otherwise as required under Section 317 of the California General Corporation Law, but such indemnification or advancement of expenses may be provided by the Company
in specific cases if the Board of Directors has approved the initiation or bringing of such suit; or 
 (c) Lack of Good Faith. To
indemnify Indemnitee for any expenses incurred by the Indemnitee with respect to any proceeding instituted by Indemnitee to enforce or interpret this Agreement, if a court of competent jurisdiction determines that each of the material assertions
made by the Indemnitee in such proceeding was not made in good faith or was frivolous; or 
  

 -5- 

 (d) Insured Claims. To indemnify Indemnitee for expenses or liabilities of any type whatsoever
(including, but not limited to, judgments, fines, ERISA excise taxes or penalties, and amounts paid in settlement) which have been paid directly to Indemnitee by an insurance carrier under a policy of directors’ and officers’ liability
insurance maintained by the Company; or 
 (e) Claims Under Section 16(b). To indemnify Indemnitee for expenses and the payment
of profits arising from the purchase and sale by Indemnitee of securities in violation (of Section 16(b) of the Securities Exchange Act of 1934, as amended, or any similar successor statute. 
 9. Effectiveness of Agreement. To the extent that the indemnification permitted under the terms of certain provisions of this Agreement exceeds
the scope of the indemnification provided for in the California General Corporation Law, such provisions shall not be effective unless and until the Company’s Articles of Incorporation authorize such additional rights of indemnification. In all
other respects, the balance of this Agreement shall be effective as of the date set forth on the first page and may apply the acts or omissions of Indemnitee which occurred prior to such date if Indemnitee was an officer, director, employee or other
agent of the Company, or was serving at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, at the time such act or omission occurred. 
 10. Subrogation. In the event of payment under this Agreement, the Company shall be subrogated to the extent of that payment to all of the rights
of recovery of Indemnitee, who shall execute all papers required and shall do everything that may be necessary to secure such rights, including the execution of any documents necessary to enable the Company effectively to bring suit to enforce such
rights. 
 11. Construction of Certain Phrases. 
 (a) For purposes of this Agreement, references to the “Company” shall include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a
consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, employees or agents, so that if Indemnitee is or was a director, officer, employee or agent of such
constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, Indemnitee shall stand in the same
position under the provisions of this Agreement with respect to the resulting or surviving corporation as Indemnitee would have with respect to such constituent corporation if its separate existence had continued. 
 (b) For the purposes of this Agreement, “agent” means any person who is or was a director, officer, employee or other agent of the Company, or
is or was serving at the request of the Company as a director, officer, employee or agent of another foreign or domestic corporation, partnership, joint venture, trust or other enterprise. “Proceeding” means any threatened, pending or
completed action or proceeding, whether civil, criminal and administrative or investigative. 
  

 -6- 

 (c) For purposes of this Agreement, references to “other enterprises” shall include employee
benefit plans; references to “fines” shall include any excise taxes assessed on Indemnitee with respect to an employee benefit plan; and references to “serving at the request of the Company” shall include any service as a
director, officer, employee or agent of the Company which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants, or beneficiaries. 
 (d) Where used in this Agreement, the masculine gender includes the feminine gender. 
 12. Successors and Assigns. This Agreement shall be binding upon the Company and its successors and assigns, and shall inure to the benefit of
Indemnitee and Indemnitee’s estate, heirs, legal representatives and assigns. 
 13. Attorneys’ Fees. In the event that any
action is instituted by Indemnitee under this Agreement to enforce or interpret any of the terms hereof, Indemnitee shall be entitled to be paid all court costs and expenses, including reasonable attorneys’ fees, incurred by Indemnitee with
respect to such action, unless as a part of such action, the court of competent jurisdiction determines that each of the material assertions made by Indemnitee as a basis for such action were not made in good faith or were frivolous. In the event of
an action instituted by or in the name of the Company under this Agreement or to enforce or interpret any of the terms of this Agreement, Indemnitee shall be entitled to be paid all court costs and expenses, including reasonable attorneys’
fees, incurred by Indemnitee in defense of such action (including with respect to Indemnitee counterclaims and cross-claims made in such action), unless as a part of such action the court determines that each of Indemnitee material defenses to such
action were made in bad faith or were frivolous. 
 14. Notice. All notices, requests, demands and other communications under this
Agreement shall be in writing and shall be deemed duly given (i) if delivered by hand and receipted for by the party addressee, on the date of such receipt, or (ii) if mailed by domestic certified or registered mail with postage prepaid,
on the third business day after the date postmarked. Addresses for notice to either party are as shown on the signature page of this Agreement, or as subsequently modified by written notice. 
 15. Consent to Jurisdiction. The Company and Indemnitee each hereby irrevocably consent to the jurisdiction of the courts of the State of
California for all purposes in connection with any action or proceeding which arises out of or relates to this Agreement and agree that any action instituted under this Agreement shall be brought only in the state courts of the State of California.

 16. Choice of Law. This Agreement shall be governed by and its provisions construed in accordance within the laws of the State of
California as applied to contracts between California residents entered into and to be performed entirely within California. 
 17. Entire
Agreement, Amendment. This Agreement contains the entire integrated Agreement between the parties hereto concerning the subject matter hereof and supersedes all prior negotiations, representations or agreements, whether written or oral, except
for the Company’s Articles of Incorporation and Bylaws. It may be amended only by a written instrument signed by a duly authorized officer of Company and by Indemnitee. 
  

 -7- 

 18. Section Headings. The Section and Subsection headings in this Agreement are solely for
convenience and shall not be considered in its interpretation. 
 19. Counterparts. This Agreement may be executed in one or more
counterparts, each of which shall constitute an original. 
 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
the date first above written. 
  

			
	UNIFIED WESTERN GROCERS, INC.
		
	 By:
	 	  

	 Title:
	 	  

	 Address:
	 	  

  

			
	AGREED TO AND ACCEPTED:
	
	INDEMNITEE:
	
	  

		
	Address:	 	  

		
		 	  

  

 -8-Asset Purchase Agreement

 EXHIBIT 10.70 
 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED
IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. 
 ASSET PURCHASE AGREEMENT 
 between 
 UNIFIED WESTERN GROCERS, INC. 
 and 
 ASSOCIATED GROCERS, INCORPORATED 
 and

 ITS SUBSIDIARIES 
 Dated as of
August 2, 2007 
  

 TABLE OF CONTENTS 
 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED
IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. 
  

					
	 	  	 	  	Page
			
	 ARTICLE 1
	  	DEFINITIONS AND INTERPRETATION	  	
			
	 Section 1.01
	  	Definitions	  	
			
	 Section 1.02
	  	Interpretation	  	
			
	 ARTICLE 2
	  	THE CONTRIBUTION	  	
			
	 Section 2.01
	  	The Contribution	  	
			
	 Section 2.02
	  	Contribution Closing	  	
			
	 Section 2.03
	  	Events of Contribution Closing	  	
			
	 ARTICLE 3
	  	PURCHASE AND SALE OF ASSETS	  	
			
	 Section 3.01
	  	Purchase and Sale	  	
			
	 Section 3.02
	  	Excluded Assets	  	
			
	 Section 3.03
	  	Assumption of liabilities	  	
			
	 Section 3.04
	  	Retained Liabilities	  	
			
	 Section 3.05
	  	Purchase Price; Adjustment	  	
			
	 Section 3.06
	  	Allocation of Purchase Price	  	
			
	 Section 3.07
	  	Further Assurances	  	
			
	 Section 3.08
	  	Washington State Taxes	  	
			
	 Section 3.09
	  	Closing	  	
			
	 Section 3.10
	  	Events of Closing	  	
			
	 ARTICLE 4
	  	REPRESENTATIONS AND WARRANTIES OF THE AG COMPANIES	  	
			
	 Section 4.01
	  	Organization	  	
			
	 Section 4.02
	  	Authority and Enforceability	  	
			
	 Section 4.03
	  	No Violation; Consents	  	
			
	 Section 4.04
	  	Financial Statements	  	
			
	 Section 4.05
	  	No Material Adverse Effect	  	
			
	 Section 4.06
	  	No Changes	  	
			
	 Section 4.07
	  	Conduct of the Company Business	  	
			
	 Section 4.08
	  	Real Property	  	

  

 i 

 TABLE OF CONTENTS 
 (continued) 
 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS
DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. 
  

					
	 	  	 	  	Page
			
	 Section 4.09
	  	Tangible Property	  	
			
	 Section 4.10
	  	Intellectual Property Rights	  	
			
	 Section 4.11
	  	Material Contracts	  	
			
	 Section 4.12
	  	Compliance with Law	  	
			
	 Section 4.13
	  	Material Permits	  	
			
	 Section 4.14
	  	Insurance	  	
			
	 Section 4.15
	  	Litigation	  	
			
	 Section 4.16
	  	Taxes	  	
			
	 Section 4.17
	  	Employee Benefits	  	
			
	 Section 4.18
	  	Employment Matters	  	
			
	 Section 4.19
	  	Labor Relations	  	
			
	 Section 4.20
	  	Environmental Matters	  	
			
	 Section 4.21
	  	Customers	  	
			
	 Section 4.22
	  	Suppliers	  	
			
	 Section 4.23
	  	Brokers and Finders Fees	  	
			
	 Section 4.24
	  	Inventory	  	
			
	 Section 4.25
	  	Acquired Receivable	  	
			
	 Section 4.26
	  	Product Warranties; Products Liability	  	
			
	 Section 4.27
	  	Solvency	  	
			
	 Section 4.28
	  	WARN Act	  	
			
	 Section 4.29
	  	No Other Representations	  	
			
	 ARTICLE 5
	  	REPRESENTATIONS AND WARRANTIES OF PURCHASER	  	
			
	 Section 5.01
	  	Organization	  	
			
	 Section 5.02
	  	Authority and Enforceability	  	
			
	 Section 5.03
	  	No Violation	  	
			
	 Section 5.04
	  	Brokers and Finders Fees	  	
			
	 Section 5.05
	  	Funding	  	
			
	 Section 5.06
	  	Litigation	  	
			
	 Section 5.07
	  	Due Diligence Investigation	  	

  

 ii 

 TABLE OF CONTENTS 
 (continued) 
 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS
DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. 
  

					
	 	  	 	  	Page
			
	 ARTICLE 6
	  	CONDUCT PRIOR TO THE CLOSING	  	
			
	 Section 6.01
	  	Affirmative Covenants of the Company	  	
			
	 Section 6.02
	  	Negative Covenants of the Company	  	
			
	 Section 6.03
	  	Consents	  	
			
	 Section 6.04
	  	Company Shareholder Approval	  	
			
	 Section 6.05
	  	Access to Information	  	
			
	 Section 6.06
	  	Public Disclosure	  	
			
	 Section 6.07
	  	HSR Compliance	  	
			
	 Section 6.08
	  	Non-Solicitation	  	
			
	 Section 6.09
	  	Proposals	  	
			
	 ARTICLE 7
	  	ADDITIONAL COVENANTS	  	
			
	 Section 7.01
	  	Expenses	  	
			
	 Section 7.02
	  	Tax Matters	  	
			
	 Section 7.03
	  	Employees	  	
			
	 Section 7.04
	  	Real Estate Documents	  	
			
	 Section 7.05
	  	SAS 100 Review	  	
			
	 Section 7.06
	  	Collection of Accounts Receivable	  	
			
	 Section 7.07
	  	Membership in Purchaser	  	
			
	 Section 7.08
	  	Access to Information; Transition Services	  	
			
	 ARTICLE 8
	  	CONDITIONS TO THE ACQUISITION	  	
			
	 Section 8.01
	  	Conditions to Each Party’s Obligation to Effect the Acquisition	  	
			
	 Section 8.02
	  	Additional Conditions to the Obligations of Purchaser	  	
			
	 Section 8.03
	  	Additional Conditions to the Obligations of the AG Companies	  	
			
	 ARTICLE 9
	  	TERMINATION, AMENDMENT AND WAIVER	  	
			
	 Section 9.01
	  	Termination	  	
			
	 Section 9.02
	  	Effect of Termination	  	
			
	 Section 9.03
	  	Termination Fee	  	
			
	 Section 9.04
	  	Amendment	  	

  

 iii 

 TABLE OF CONTENTS 
 (continued) 
 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS
DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. 
  

					
	 	  	 	  	Page
			
	 Section 9.05
	  	Extension; Waiver	  	
			
	 ARTICLE 10
	  	GENERAL PROVISIONS	  	
			
	 Section 10.01
	  	Survival and Survival Exclusive Remedies	  	
			
	 Section 10.02
	  	Notices	  	
			
	 Section 10.03
	  	Disclosure Schedules	  	
			
	 Section 10.04
	  	Entire Agreement; No Assignment; No Third Party Beneficiaries	  	
			
	 Section 10.05
	  	Severability	  	
			
	 Section 10.06
	  	Specific Performance	  	
			
	 Section 10.07
	  	Waiver of Jury Trial	  	
			
	 Section 10.08
	  	Governing Law; Venue	  	
			
	 Section 10.09
	  	No Personal Liability	  	
			
	 Section 10.10
	  	Counterparts	  	
			
	 Section 10.11
	  	Attorneys’ Fees	  	
			
	 Exhibit A
	  	Definitions	  	
			
	 Exhibit B
	  	Form of Bill of Transfer*	  	
			
	 Exhibit C
	  	Form of Assignment of LLC Interests*	  	
			
	 Exhibit D
	  	Form of Bill of Sale*	  	
			
	 Exhibit E
	  	Form of Assignment and Assumption Agreement*	  	
			
	 Exhibit F
	  	Form of Norfolk Lease Assignment and Assumption Agreement*	  	
			
	 Exhibit G
	  	Form of Intercreditor Agreement*	  	
			
	 Exhibit H
	  	Form of Escrow Agreement*	  	
			
	 Exhibit I
	  	Form of Estoppel Certificate*	  	
			
	 Exhibit J
	  	Form of Supply Agreement*	  	
			
	 Exhibit K
	  	Company Knowledge Group*	  	

  

 iv 

 TABLE OF CONTENTS 
 (continued) 
 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS
DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. 
 INDEX OF SCHEDULES 
 to 
 Asset Purchase Agreement between Unified
Western Grocers, Inc. 
 and Associated Grocers, Incorporated and its Subsidiaries 
  

			
	 	  	Page
		
	Schedule 2.01(a)—All tangible personal property.*	  	
		
	Schedule 3.01(a)—All real property.*	  	
		
	Schedule 3.01(b)—Leases of real property.*	  	
		
	Schedule 3.01(c)—All contracts, agreements, indentures, mortgages, instruments, guarantees, commitments, understandings, purchase orders, sales orders, documents and
instruments.*	  	
		
	Schedule 3.01(d)—All patents, trademarks, trade names, copyrights and service marks; registrations therefore, applications pending therefore; other proprietary rights and
intangible property of the AG Companies, including trade secrets, technology, software, internet mail sites, internet domain names, operating systems, customer lists, customer relationships, know–how, formulae, slogans, processes and operating
rights.*	  	
		
	Schedule 3.01(e)—All licenses and agreements relating to any items described in Section 3.01(d) or to other proprietary rights transferred hereby.*	  	
		
	Schedule 3.01(f)—To the extent transferable and permitted by law, all approvals, authorizations, certificates, consents, licenses, permits, franchises, tariffs, variances, orders and
other registrations of any federal, state or local court or other governmental department, commission, board, bureau, agency or instrumentality held by the Company or any of the Subsidiaries and required for the conduct of the
Business.*	  	

  

 v 

 TABLE OF CONTENTS 
 (continued) 
 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS
DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. 
  

			
	 	  	Page
		
	Schedule 3.01(g)—Notes and other receivables.*	  	
		
	Schedule 3.01(k)—All assignable rights to all telephone lines and numbers used in the conduct of the Business.*	  	
		
	Schedule 3.02(c)—Items to be included in Excluded Assets.*	  	
		
	Schedule 3.03(a)—Items to be included in Purchaser’s Assumed Liabilities.*	  	
		
	Schedule 3.03(d)—Assumed Plans.*	  	
		
	Schedule 3.05(b)(1)—Purchased Working Capital.*	  	
		
	Schedule 3.05(b)(2)—Reserves.*	  	
		
	Schedule 3.06—Method for Allocation of Purchase Price.*	  	
		
	Company Disclosure Schedule*	  	
		
	 4.04(a)—Financial Statements.*
	  	
		
	 4.05—No Material Adverse Effect.*
	  	
		
	 4.06—No Changes.*
	  	

  

 vi 

 TABLE OF CONTENTS 
 (continued) 
 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS
DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. 
  

			
	 	  	Page
		
	 4.07—Conduct of the Business.*
	  	
		
	 4.08(a)(1)—Owned Real Property.*
	  	
		
	 4.08(b)—Leased Real Property.*
	  	
		
	 4.08(c)—Loans and Mortgages.*
	  	
		
	 4.09—Tangible Property. *
	  	
		
	 4.10—Material IP Rights.*
	  	
		
	 4.11—Material Contracts.*
	  	
		
	 4.12—Compliance with Law.*
	  	
		
	 4.13—Material Permits.*
	  	
		
	 4.14—Insurance policies.*
	  	
		
	 4.15—Litigation.*
	  	
		
	 4.16—Taxes.*
	  	
		
	 4.17—Employee Benefits.*
	  	

  

 vii 

 TABLE OF CONTENTS 
 (continued) 
 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS
DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. 
  

			
	 	  	Page
		
	 4.18—Employment Matters.*
	  	
		
	 4.19—Labor Relations.*
	  	
		
	 4.20—Environmental Matters.*
	  	
		
	 4.21—Customers.*
	  	
		
	 4.22—Suppliers.*
	  	
		
	 4.23—Brokers and Finders Fees.*
	  	
		
	 4.24—Inventory. *
	  	
		
	 4.25—Acquired Accounts Receivable.*
	  	
		
	 4.26—Product warranties; Product Liability.*
	  	
		
	 4.27—Solvency.*
	  	
		
	 4.28—WARN Act.*
	  	
		
	 6.02—Negative Covenants of the Company.*
	  	
		
	 8.01(e)—Required Consents.*
	  	

	*	Intentionally Omitted. Omitted exhibits and schedules will be furnished to the SEC or SEC staff upon request. 

  

 viii 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 ASSET PURCHASE AGREEMENT 
  

					
	Dated:	  	August 2, 2007	  	
			
	Among:	  	Associated Grocers, Incorporated, a Washington corporation	  	“Company”
			
		  	 Supermarket Development Corporation
Market Finance Company
MFC Capital-I, Ltd.
MFC 2002, LLC
AGIC Insurance Agency, Inc.
Market
Industrial Relations Services, Inc.
Market Sales, Inc.
Sea-Pac Freight Lines, Inc.
Supermarket Management Corporation
Red Apple Stores, Inc.
Thriftway Stores, Inc.
 AU Dropdown LLC
	  	 Each a “Subsidiary”
 and together with the
 Company, the “AG
 Companies”

			
	And:	  	Unified Western Grocers, Inc., a California corporation	  	“Purchaser”

 Recitals 
 A. The AG Companies (other than the LLC) desire to sell, and Purchaser desires to purchase and assume, specified assets and specified liabilities of the AG Companies, including the limited liability company interests
of AU Dropdown LLC (the “LLC”), which is wholly owned by the Company, on the terms and conditions set forth in this Agreement (the “Acquisition”) and, in furtherance thereof, the AG Companies and Purchaser have
approved the execution, delivery, and performance of this Agreement and the other agreements contemplated herein. 
 B. The parties desire to
make certain representations, warranties, covenants, and agreements in connection with the Acquisition and to prescribe various conditions to the completion thereof, all as further set forth herein. 
 Agreement 
 Accordingly, the parties,
intending legally to be bound, agree as follows: 
  

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Article 1 
 Definitions And Interpretation 
 Section 1.01 Definitions. Capitalized terms used herein have
the meanings set forth in this Agreement or Exhibit A hereto. 
 Section 1.02 Interpretation. The following rules of
interpretation apply throughout this Agreement: 
 (a) The word “or” is used in the inclusive sense of
“and/or”. The word “including” (and “include” and variations thereof) means including without limiting the generality of any description preceding such term. The words “hereof,” “herein,”
“hereby,” “hereunder,” and similar terms in this Agreement refer to this Agreement as a whole and not to any particular provision of this Agreement. 
 (b) The headings in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this
Agreement. Except as otherwise indicated, all references in this Agreement to Articles, Sections, and Exhibits are intended to refer to Articles or Sections of this Agreement and Exhibits to this Agreement. 
 (c) The singular number shall include the plural, the plural shall include the singular, and the use of any gender shall be applicable to
both genders. 
 (d) Unless otherwise specified, all references to monetary amounts are to currency of the United States of
America. 
 (e) Unless otherwise specified, all terms of an accounting character used but not defined in this Agreement shall
be interpreted in accordance with GAAP, applied on a basis consistent with the most recent audited consolidated financial statements of the Company. 
 (f) When calculating the period of time before which, within which or following which any act is to be done or step is to be taken under this Agreement, the reference date in calculating such period shall be excluded.
If the last day of such period is a non-Business Day, the period in question shall end on the next succeeding Business Day. 
 (g) The language used in this Agreement shall be deemed to be the language chosen by the parties hereto to express their mutual agreement; any Law, regulation, or rule of construction to the effect that ambiguities are to be resolved
against the drafting party shall not be applied in the construction or interpretation of this Agreement. 
  

 2 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Article 2 
 The Contribution 
 Section 2.01 The Contribution. Subject to all the terms and conditions of
this Agreement, on the Closing Date and effective immediately prior to the purchase of assets under Section 3.01, the Company shall contribute or cause to be contributed to the LLC, as a contribution of capital and for no consideration other
than the limited liability company interests in the LLC (the “LLC Interests”), and cause the LLC to accept and assume from the Company, all right, title and interest of the Company (other than the Excluded Assets specified in
Section 3.02(a)-(m)) to the following assets (the “Contributed Assets”): 
 (a) All items of tangible
personal property of the AG Companies, including furniture, fixtures, equipment, materials, supplies, motor vehicles and spare and replacement items therefore, including all such items listed on Schedule 2.01(a) and all such items acquired by
the AG Companies after the date hereof and on or before the Closing Date, other than to the extent such items are disposed of by any of the AG Companies prior to the Closing Date without breach of this Agreement; and 
 (b) All inventory (the “Inventory”) wherever located, provided that the term “Inventory” excludes inventory
associated exclusively with the Larry’s Market store located in Redmond, Washington (the “Retail Store”). 
 Section 2.02 Contribution Closing. The closing of the Contribution will take place immediately prior to the Closing. 
 Section 2.03 Events of Contribution Closing. Immediately prior to the Closing, (a) the Company shall deliver to the LLC a bill of transfer in substantially the form attached as Exhibit B, transferring the Contributed
Assets to the LLC, executed by the Company and (b) the LLC shall deliver to the Company a Washington State Department of Revenue resale certificate. 
 Article 3 
 Purchase And Sale Of Assets 
 Section 3.01 Purchase and Sale. Subject to all the terms and conditions of this Agreement and for the consideration herein stated, on the Closing
Date, the AG Companies agree to sell, convey, assign, transfer and deliver to Purchaser, and Purchaser agrees to purchase and accept from the AG Companies, all of the right, title and interest of the AG Companies in and to all of the assets,
properties and rights of the AG Companies (other than the Contributed Assets and the other Excluded Assets specified in Section 3.02), tangible and intangible, wherever located, including all such assets used in the wholesale distribution
business serving independent grocery retailers in Washington, Oregon, Alaska, Hawaii and Micronesia (the 
  

 3 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 “Business”) now owned and operated by the Company, which assets (the “Purchased
Assets”) shall include without limitation the following assets (other than the Excluded Assets): 
 (a) All real
property owned in fee by any of the AG Companies, including land, improvements and fixtures thereon, easements, rights-of-way and other real property rights, including all such real property listed on Schedule 3.01(a) and all such real
property acquired by the AG Companies after the date hereof and on or before the Closing Date, other than to the extent such items are disposed of by the AG Companies prior to the Closing Date without breach of this Agreement; 
 (b) The following leases of real property (collectively, the “Leases”): (i) the Industrial Real Estate Lease dated
April 19, 2007 (the “Norfolk Lease”) between 3301 South Norfolk LLC as landlord and the Company as tenant for the lease of the real property commonly known as 3301 South Norfolk Street, Seattle, Washington, and
(ii) the leases of real property to which any of the AG Companies is a party, whether the Company or a Subsidiary is lessor or lessee, listed on Schedule 3.01(b). 
 (c) All rights, benefits and interests of any of the AG Companies under all contracts, agreements, indentures, mortgages, instruments,
guarantees, commitments, understandings, purchase orders, sales orders, documents and instruments (i) listed on Schedule 3.01(c) hereto, (ii) entered into in the ordinary course of the Business and that are not Material Contracts or
(iii) expressly assumed by Purchaser in writing, other than (in each case) to the extent such items have terminated, expired or been disposed of by any of the AG Companies prior to the Closing Date without breach of this Agreement; provided
that, except as otherwise expressly agreed in writing by Purchaser, a guarantee or other contingent obligation of the Company to support the credit of a retail customer of the Company will be excluded if the retail customer does not enter into a
Supply Agreement with Purchaser at or before the Closing (collectively, the “Contracts”); 
 (d) All patents,
trademarks, trade names, copyrights and service marks of any of the AG Companies, all registrations therefor, all applications pending therefor and all other proprietary rights and intangible property of the AG Companies, including trade secrets,
technology, software, internet mail sites, internet domain names, operating systems, customer lists, customer relationships, know-how, formulae, slogans, processes and operating rights, including all such items listed on
Schedule 3.01(d), goodwill associated therewith, remedies against infringement thereof and rights to protection of interests therein under the laws of all jurisdictions and all such items acquired by the AG Companies or coming into
existence after the date hereof and on or before the Closing Date, other than to the extent such items have terminated, expired or been disposed of by the AG Companies prior to the Closing Date without breach of this Agreement (the
“Intellectual Property”); 
 (e) All licenses granted by or to any of the AG Companies and all other
agreements to which any of the AG Companies is a party which relate, in whole or in part, to any items described in Section 3.01(d) or to other proprietary rights transferred hereby, 

  

 4 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 including all items listed on Schedule 3.01(e) and all such items granted to or entered
into by any of the AG Companies after the date hereof and on or before the Closing Date, other than to the extent such items have terminated, expired or been disposed of by any of the AG Companies prior to the Closing Date without breach of this
Agreement (the “Intellectual Property Rights”); 
 (f) To the extent transferable and permitted by law, all
approvals, authorizations, certificates, consents, licenses, permits, franchises, tariffs, variances, orders and other registrations of any federal, state or local court or other governmental department, commission, board, bureau, agency or
instrumentality held by the Company or any of the Subsidiaries and required for the conduct of the Business, including all such items listed on Schedule 3.01(f) and all such items granted or received after the date hereof and on or before the
Closing Date, other than to the extent such items have terminated, expired or been disposed of by the Company or any of the Subsidiaries prior to the Closing Date without breach of this Agreement (the “Permits”); 
 (g) The notes and other receivables of any of the AG Companies listed on Schedule 3.01(g) and the other receivables of the AG
Companies that are not Excluded Accounts Receivable, in each case excluding amounts paid on or before the Closing Date in the ordinary course according to the terms of the note or other receivable without acceleration (“Acquired
Receivables”); 
 (h) All claims, refunds, rights of recovery, rights of set-off, rights of recoupment, choses in
action, causes of action, property insurance proceeds, condemnation awards, proceeds from any contests or contested payments and other similar rights of any of the AG Companies to the extent related to the Purchased Assets or the Contributed Assets;

 (i) All prepaid and deferred items of the AG Companies (other than deferred tax assets), including prepaid rent and
unbilled charges and deposits relating to the Business, the Purchased Assets or the Contributed Assets, including all such items reflected on the Financial Statements; 
 (j) All operating data and records to the extent related to the Business, including financial, accounting and credit records, original
records relating to the LLC (including its articles of formation, operating agreement and minutes of its sole member and manager), correspondence, budgets, engineering and plant records and other similar documents and records and all creative
materials, advertising and promotional materials, studies, reports and other similar documents and materials; 
 (k) All
assignable rights, if any, to all telephone lines and numbers used in the conduct of the Business, including those listed on Schedule 3.01(k); 
  

 5 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (l) All assets, wherever located, used exclusively in the insurance agency
operations of any of the AG Companies (excluding Excluded Accounts Receivable as defined below); 
 (m) All cash and cash
equivalents of the AG Companies except as provided in Section 3.02(m); 
 (n) All rights to recover amounts any of the AG
Companies paid or expensed in calendar years 2006 and 2007 to a vendor that is recoverable following an audit of such amounts; 
 (o) All deposits and other collateral (i) of each retail customer of the Company that enters into a Supply Agreement with Purchaser at or before the Closing or whose supply agreement is assumed by Purchaser, which deposit or other
collateral secures open account balances with any AG Company and (ii) that secures a Purchased Asset or an Assumed Liability, provided that such deposits and other collateral shall be subject to the intercreditor agreement described in
Section 3.10(a)(5) and the applicable assignment and assumption agreement described in Section 3.10(a)(3); and 
 (p) The LLC Interests and the limited liability company interests in AG/Fleming Northwest, LLC. 
 Section 3.02 Excluded
Assets. The Purchased Assets shall not include the following (the “Excluded Assets”): 
 (a) The
corporate seal, minute books, charter documents and corporate stock record books of each of the AG Companies (except for the LLC) and copies of all other records of any kind; 
 (b) Any contract, agreement, indenture, mortgage, instrument, guaranty, commitment, understanding, purchase order, sales order, document
or instrument that is not described in Section 3.01(c); 
 (c) The assets identified on Schedule 3.02(c);

 (d) Any deferred tax assets; 
 (e) All leases or subleases that are not described in Section 3.01(b); all rights, benefits and interests of any of the AG Companies under or relating to any of the foregoing; any deposit relating
exclusively to any of the foregoing; any guaranties to secure any of the foregoing; and all records, databases and software programs relating exclusively to or used exclusively in connection with any of the foregoing, including the Access and
Timberline databases and software programs; 
  

 6 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (f) All accounts receivable or other receivables of any of the AG Companies that
are due within 60 days of the Closing Date (the “Excluded Accounts Receivable”); 
 (g) All rebates,
promotions, warehouse directed funds, discounts, vendor programs, patronage dividends and similar items which are in existence as of Closing or are attributable to conduct of the Business before Closing and which the AG Companies treat as
discretionary funds consistent with their historical practices (the “Discretionary Funds”); 
 (h) All
inventories that do not constitute Inventory; 
 (i) All assets, wherever located, used primarily in the Retail Store;

 (j) All rights and claims associated with all litigation ongoing as of the Closing, including SuperValu Inc. v. Associated
Grocers, Inc. (Civil File No. 04-2936), in the United States District Court for the District of Minnesota (the “SUPERVALU Litigation”), and In re Brown and Cole Stores, LLC, Case No. 06-13950, pending in the United States
Bankruptcy Court for the Western District of Washington (the “Brown and Cole Litigation”); 
 (k) (A) All
claims, refunds, rights of recovery, rights of set-off, rights of recoupment, choses in action, causes of action, property insurance proceeds, condemnation awards, proceeds from any contests or contested payments and other similar rights of any of
the AG Companies (except the LLC) to the extent related to any of the following: (1) an Excluded Asset or Retained Liability, (2) a Governing Document of an AG Company (except the LLC), (3) all Taxes for which an AG Company is
responsible, and (4) all defenses, counter-claims, subordination rights, claims, choses in action, causes of action, and other rights of any of the AG Companies associated with any claim or demand against any of the AG Companies now existing
(other than the LLC); (B) all insurance policies and rights thereunder; and (C) all refunds, recoveries, awards and proceeds arising from the litigation involving the Focus on Foods store in Longview, Washington; 
 (l) All assets, properties and rights that have been sold to [REDACTED] or its affiliates and all rights, benefits and interests of
any of the AG Companies or their Affiliates with respect to such sale, including with respect to that certain Real Property Purchase and Sale Agreement dated as of [REDACTED] between [REDACTED] as buyer and [REDACTED] as seller
and that certain Escrow Agreement among [REDACTED] as buyer, [REDACTED] as seller and [REDACTED] as escrow agent (other than the deposit paid under the Norfolk Lease, which is a Purchased Asset); 
 (m) The amount of cash [REDACTED] received from the sale described in Section 3.02(l) (which was [REDACTED] plus
[REDACTED] in cash; 
 (n) All of the stock or other ownership interests of whatever type in any of the AG Companies,
except for the LLC Interests; 
  

 7 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (o) All collateral held by any AG Company that secures an Excluded Asset, all
collateral that secures an obligation by a subtenant under a sublease that is an Excluded Asset, and all guaranties that secure an Excluded Asset; provided that the following are Purchased Assets: (i) deposits identified as Purchased
Assets in Schedule 3.05(b)(1), (ii) each security agreement by a retail customer as debtor or grantor that is listed in Schedule 3.01(c) if the retail customer signs a Supply Agreement on or before Closing or whose supply
agreement is assumed by Purchaser and (iii) each security agreement by a debtor that is listed in Schedule 3.01(c) and that secures an Acquired Receivable; further provided that (A) any assignment of a security agreement
described in clause (ii) or (iii) is only for the purpose of securing obligations of the customer incurred after Closing and, if the customer is an obligor of an Acquired Receivable, for the purpose of securing obligations of the customer
under such Acquired Receivable and (B) the following are Excluded Assets: (1) all rights, title and interest in any stock or securities of the Company and the proceeds thereof and (2) all of the AG Companies’ respective rights,
title, interest, duties, liabilities and obligations in, to and under the security agreements and related documents for the purpose of securing Excluded Accounts Receivable; and 
 (p) The Contributed Assets. 
 Section 3.03 Assumption of liabilities. Subject to the terms and conditions of this Agreement, on the Closing Date, Purchaser shall assume and discharge, pay, and honor when due, and from and after the Closing Date Purchaser shall
indemnify the AG Companies against all Losses with respect to, the following liabilities and obligations of the AG Companies (the “Assumed Liabilities”): 
 (a) The liabilities and obligations of the AG Companies described on Schedule 3.03(a) to the extent and in the amounts recorded on
the Company’s consolidated balance sheet (not including any notes thereto) as of the Closing Date (the “Closing Balance Sheet”); 
 (b) All liabilities and obligations under all of the Intellectual Property Rights, Leases and Contracts incurred after the Closing Date; 
 (c) Any additional liabilities and obligations expressly assumed by Purchaser in writing, including in Section 7.03(d); and

 (d) Subject to Sections 7.03(c) and (d), the liabilities and obligations of the AG Companies under the Seller Benefit Plans
listed on Schedule 3.03(d) (the “Assumed Plans”). 
 Section 3.04 Retained Liabilities. Except for the
liabilities and obligations to be assumed by Purchaser pursuant to Section 3.03, Purchaser will not assume and will not be liable for any liabilities of any of the AG Companies, known or unknown, contingent or absolute, accrued or other (the
“Retained Liabilities”), which Retained Liabilities include, without 
  

 8 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 limitation, the following (provided, however, that the following items do not limit the scope or extent of the
Assumed Liabilities): 
 (a) Liabilities, obligations or debts of any of the AG Companies, whether fixed, contingent or mixed
and whether based on events occurring before or after the Closing, including those based on tort, contract, statutory or other claims or involving fines or penalties payable to any governmental authority, that are not recorded, or exceed the amounts
recorded, on the Closing Balance Sheet; 
 (b) Liabilities, obligations or debts, if any, of any of the AG Companies to
General Electric Capital Corporation, including under the Credit Agreement dated as of October 6, 2005 among Associated Grocers, Incorporated, as Borrower, the other credit parties signatory thereto, as credit parties, and General Electric
Capital Corporation, as Lender, as amended; 
 (c) Liabilities or obligations with respect to leases, subleases, guarantees or
other financial commitments of the AG Companies that are not Purchased Assets; 
 (d) Except as otherwise provided in this
Agreement, liabilities, obligations or debts of any of the AG Companies for any federal, state, local or foreign tax, including federal income taxes, state income and excise taxes, state and local real and personal property taxes, customs duties,
value added tax, and federal, state, local and foreign withholding and payroll taxes; 
 (e) Except for the Assumed Plans and
except as provided in Section 7.03(c), (d) and (e), liabilities or obligations of any of the AG Companies or any of their ERISA Affiliates with respect to a Seller Benefit Plan or for salaries, bonuses, health and welfare benefits, workers
compensation or for any other benefits or compensation (including accrued vacation), including those pursuant to employment agreements and industrial insurance obligations; 
 (f) Liabilities or obligations of any of the AG Companies or any of their ERISA Affiliates for employee severance payments or arrangements
resulting from termination of the employees of any of the AG Companies or their ERISA Affiliates; 
 (g) Liabilities or
obligations of any of the AG Companies relating to issuances of the stock or other ownership interests of whatever type in any of the AG Companies; 
 (h) Liabilities or obligations of any of the AG Companies incurred in connection with distributions to shareholders or members or in connection with any corporate or other dissolution; 
  

 9 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (i) Liabilities or obligations of any of the AG Companies incurred with respect to
any litigation, including the SUPERVALU Litigation and the Brown and Cole Litigation; 
 (j) Any obligations or liabilities
primarily related to the Retail Store or any other retail stores of any of the AG Companies; and 
 (k) Liabilities or
obligations of any of the AG Companies for Washington and Seattle business and occupation tax relating to Western Family Foods, Inc. 
 Section 3.05 Purchase Price; Adjustment. 
 (a) Purchase Price; Payment. The purchase price for the
Purchased Assets (the “Purchase Price”) shall be [REDACTED] as adjusted 
 (1) at the Closing, by
(i) the Estimated Closing Purchased Working Capital Adjustment, (ii) the Estimated Closing Reserves; (iii) Supply Agreement Adjustment, (iv) the Tax Adjustment; and (iv) the Long Term Asset Adjustment, and 
 (2) after the Closing, by the Post-Closing Adjustment. 
 At the Closing, Purchaser shall pay to the Company, in immediately available funds, an amount (the “Closing Payment”) equal to (i) [REDACTED] as adjusted by (A) the Estimated Closing
Purchased Working Capital Adjustment, (B) the Estimated Closing Reserves; (C) the Supply Agreement Adjustment, (D) the Tax Adjustment and (E) the Long Term Asset Adjustment, less (ii) [REDACTED] (the “Holdback
Amount”), which Purchaser shall retain to secure payment of the Post-Closing Adjustment, less (iii) the Withdrawal Liability Amount calculated under Section 7.03(d), which Purchaser shall deposit in an interest-bearing escrow
account to secure payment of the Withdrawal Liability. 
 (b) Closing Adjustments. The Purchase Price shall be adjusted
as follows: 
 (1) Purchased Working Capital. A detailed schedule of the assets and liabilities and accounting
principles and methods used to calculate the Purchased Working Capital is attached to this Agreement as Schedule 3.05(b)(1). At the Closing, the Company shall deliver to Purchaser a statement of Estimated Closing Purchased Working Capital as
of the Closing Date (the “Statement of Estimated Closing Purchased Working Capital”) and work papers setting forth the basis for calculating the Estimated Closing Purchased Working Capital, which shall be prepared in accordance with
Section 3.05(d). The Statement of Estimated Closing Purchased Working Capital shall specify the amount by which the Estimated Closing Purchased Working Capital is greater than the Target Purchased Working Capital, which amount shall be added to
the Closing Payment, or less than the Target Purchased Working Capital, which amount shall be deducted from the Closing Payment (the “Estimated Closing Purchased Working Capital Adjustment”). 
  

 10 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (2) Reserves. A detailed schedule of the items, and accounting principles
and methods, used to calculate Reserves is attached to this Agreement as Schedule 3.05(b)(2). At the Closing, the Company shall deliver to Purchaser a statement of Estimated Closing Reserves as of the Closing Date (the “Statement of
Estimated Closing Reserves”) and work papers setting forth the basis for calculating the Estimated Closing Reserves, which shall be prepared in accordance with Section 3.05(d). The Statement of Estimated Closing Reserves shall specify
the amount by which the Estimated Closing Reserves is less than the Target Reserves, which amount shall be added to the Closing Payment, or greater than the Target Reserves, which amount shall be deducted from the Closing Payment (the
“Estimated Closing Reserves Adjustment”). 
 (3) Supply Agreements. The Closing Payment will be
adjusted (the “Supply Agreement Adjustment”) 
 (i) upward by an amount equal to [REDACTED] x ((AU
– [REDACTED]) ÷ [REDACTED]), where “AU” is the aggregate amount of committed annual purchases reflected in Supply Agreements executed on or before the Closing Date, provided that AU shall not exceed
[REDACTED] and that there shall be no adjustment under this clause (i) if AU is less than [REDACTED]  
 (ii) downward by an amount equal to [REDACTED] x (([REDACTED] – AD) ÷ [REDACTED]), where “AD” is the aggregate amount of committed annual purchases reflected in Supply Agreements executed on or
before the Closing Date, provided that AD shall not exceed [REDACTED] and that there shall be no adjustment under this clause (ii) if AD is greater than [REDACTED]; and 
 (iii) downward by [REDACTED] if [REDACTED]. 
 For purposes of negotiating the amount of annual committed purchases in a Supply Agreement with a Qualified Retailer, the parties shall use commercially reasonable efforts to cause the amount of the annual committed
purchase reflected in the Supply Agreement to be no less than the Qualified Retailer’s total purchases from the AG Companies in the 12-month period ended June 8, 2007, as reflected in the books and records of the AG Companies. Within 5
days prior to the scheduled Closing Date, Purchaser and the Company shall deliver to each other any Supply Agreement that has been signed by Qualified Retailers and [REDACTED], together with Purchaser and the Company’s calculation of the
Supply Agreement Adjustment (the agreed upon calculation of the Supply Agreement Adjustment is referred to as the “Statement of Supply Agreement Adjustment”). At Closing, the Company and Purchaser shall each deliver to the other any
Supply Agreements that it received and did not deliver to the other before Closing and shall agree upon the final Statement of Supply Agreement Adjustment. The parties agree that committed annual purchases contained in any agreement assumed by
Purchaser, and not in a Supply Agreement, shall not be considered committed annual purchases for purposes of this Section 3.05(b)(3). 
  

 11 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 At Closing, the applicable AG Companies will waive, for itself and for its successors and assigns
and providing in that waiver that Purchaser is an intended third party beneficiary thereof, each of their retail customers’ obligations under any supply agreement between an AG Company and the retail customer that are Excluded Assets, whether
such supply agreement is part of a lease, sublease, stand-alone arrangement or otherwise, to allow each such retail customer to enter into a Supply Agreement with Purchaser or otherwise to purchase goods from Purchaser, in each case subject to
either (x) the retail customer having executed and delivered to the Company a written waiver of any supply obligation of any of the AG Companies reasonably acceptable to the Company in a Supply Agreement or otherwise, or (y) Purchaser
having assumed any supply obligation of the AG Companies with respect to the existing supply agreement. 
 (4) Long Term
Assets. The Closing Payment shall be adjusted (the “Long Term Asset Adjustment”) (i) [REDACTED], as of the Closing Date, of any non-current Purchased Asset that was not reflected on the January Balance Sheet and (ii)
[REDACTED] at the time of sale of any non-current asset reflected on the January Balance Sheet that would have been a Purchased Asset but that was sold, collected (other than in the ordinary course as provided in Section 3.01(g)) or
otherwise disposed of before the Closing Date. Notwithstanding the foregoing, there will be no Long Term Asset Adjustment (and no Purchase Price reduction) on account of (i) any asset that had a book value of zero on the January Balance Sheet;
(ii) any asset that any of the AG Companies sold to Sabey Corporation or its affiliates in connection with and contemporaneously with execution by the Company of the Norfolk Lease; and (iii) any reduction in the book value of non-current
assets between the date of the January Balance Sheet and the Closing Date solely due to depreciation or amortization of non-current assets owned by any of the AG Companies as of the Closing Date. The parties agree that, as of the date of this
Agreement, the Long Term Asset Adjustment will include an [REDACTED]. 
 (c) Post-Closing Adjustment.

 (1) Purchased Working Capital and Reserves. As soon as practicable, but in any event within 45 calendar days
following the Closing Date, Purchaser will prepare and deliver to the Company the Closing Balance Sheet and a statement, including work papers setting forth the basis for calculating, of the Closing Purchased Working Capital (the “Statement
of Closing Purchased Working Capital”) and a statement, including work papers setting forth the basis for calculating, of the Closing Reserves (the “Statement of Closing Reserves” and, together with the Statement of Closing
Purchased Working Capital, the “Statement of Post-Closing Adjustment”). The Statement of Post-Closing Adjustment shall be prepared in accordance with Section 3.05(d). Subject to the resolution of any disputes pursuant to
Section 3.05(c)(2), the Holdback Amount shall be adjusted (the “Post-Closing Adjustment”) (i) downward by the amount, if any, by which the Estimated Closing Purchased Working Capital exceeds the Closing Purchased Working
Capital and by the amount, if any, by which Estimated Closing Reserves is less than the Closing Reserves and (ii) upward by the amount, if any, by which the Estimated Closing Purchased Working Capital is less than the Closing Purchased Working
Capital and by the amount, if any, by which the Estimated Closing Reserves exceeds the Closing Reserves. Purchaser shall pay to the Company the Holdback Amount as adjusted by 

  

 12 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 the Post-Closing Adjustment, if positive, by the 60 days following the Closing Date unless the
Company, in good faith, disputes the calculation of the Post-Closing Adjustment, in which case the Purchaser shall pay to the Company the undisputed portion of the Holdback Amount derived from the Dispute Notice (as defined in
Section 3.05(c)(2)(i)) by such time and the balance of the Holdback Amount, if any, on the date specified in Section 3.05(c)(2)(iii). 
 (2) Dispute Resolution. 
 (i) If the Company, in good faith, disputes the calculation
of the Post-Closing Adjustment, the Company shall notify Purchaser in writing (the “Dispute Notice”) setting forth in reasonable detail the items, amount, nature and basis of such dispute, within 15 calendar days after receipt of
the Statement of Post-Closing Adjustment. In the event of such a dispute, the Company and Purchaser shall first use their diligent good faith efforts to resolve the dispute between themselves. If the parties are unable to resolve any items in
dispute within 15 calendar days after delivery of the Dispute Notice, the unresolved items in dispute shall be submitted to an independent accounting firm other than [REDACTED] and with no material relationship to either the Company or
Purchaser. The firm shall be mutually agreed upon by the Company and Purchaser or, if the Company and Purchaser fail to agree upon or refuse to select such a firm within 10 calendar days after written request therefor by either of them, an
independent accounting firm shall be selected by the Company and Purchaser in accordance with the rules of the American Arbitration Association then in effect (the selected accounting firm shall be referred to as the “Arbitrator”).
The Company and Purchaser shall instruct the Arbitrator to resolve the remaining disputed items, applying the principles in Section 3.05(d), and deliver within 45 calendar days a written report to the Company and Purchaser with respect to the
items. The Arbitrator shall, in connection with the resolution of any dispute, have access to all books and records, documents, work papers, facilities and personnel necessary to perform its functions as arbitrator. The Arbitrator’s decision
shall be final, conclusive and binding on all parties. A judgment on the determination made by the Arbitrator pursuant to this Section 3.05(c)(2)(i) may be entered into and enforced by any court of appropriate jurisdiction. 
 (ii) The fees and expenses of the Arbitrator in connection with the resolution of disputes pursuant to Section 3.05(c)(2)(i) shall
be (i) borne equally by the Company and Purchaser if and to the extent that the Arbitrator determines the Company and Purchaser should each be awarded one-half of the total amount of the items in dispute, or (ii) borne by the Company
and/or Purchaser in inverse proportion to the amount that the Arbitrator’s award in favor of the Company and/or Purchaser bears to the total amount of the items in dispute. (For illustration purposes for this Section 3.05(c)(2) only,
(x) if the total amount of items in dispute by the Company is $1,000,000.00, and the Company is awarded $500,000.00 by the Arbitrator, the Company and Purchaser shall bear the Arbitrator’s fees and expenses equally, or (y) if the
total amount of items in dispute by the Company is $1,000,000.00, and the Company is awarded $250,000.00 by the Arbitrator, the Company shall bear 75% and Purchaser shall bear 25% of the Arbitrator’s fees and expenses.) 
  

 13 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (iii) Within five calendar days following the final determination of the
Post-Closing Adjustment whether by (A) the expiration of the 10 calendar day period for giving the Dispute Notice if no Dispute Notice is given or (B) the resolution of any disputes pursuant to Section 3.05(c)(2), Purchaser shall pay
the Holdback Amount as adjusted by the Post-Closing Adjustment, if positive, to the Company. 
 (d) Closing Balance Sheets
and Statements. Any balance sheet or statement prepared for purposes of this Section 3.05 shall (i) reflect the same categories and basis of assets, liabilities and reserves set forth in the January Balance Sheet, Schedule
3.05(b)(1) or Schedule 3.05(b)(2) and (ii) be prepared (A) in accordance with the accounting principles (including accounting methods, practices, and procedures) set forth on Schedule 3.05(b)(1) or Schedule
3.05(b)(2), even if such accounting principles are not in accordance with GAAP, (B) if not covered by Schedule 3.05(b)(1) or Schedule 3.05(b)(2), in accordance with the accounting principles used in the preparation of the most
recent audited year-end balance sheet of the AG Companies, and (C) to the extent such accounting principles do not address a matter necessary for the preparation of the balance sheets or statements prepared under this Agreement, in accordance
with GAAP. All balance sheets and statements referenced in this Section 3.05 shall present the assets and liabilities of the AG Companies prior to and without giving effect to the contribution of the Contributed Assets, the Acquisition or any
of the Contemplated Transactions. 
 (e) No Double-Counting. If an adjustment is made, or should have been made, to the
Purchase Price under this Section 3.05, Purchaser may not bring a claim under any other provision of this Agreement seeking recovery for Losses based on facts or circumstances that resulted or should have resulted in the adjustment. If an
adjustment is made to the Purchase Price under one provision of this Section 3.05 (“first adjustment”), Purchaser may not make an adjustment under any other provision of this Section 3.05 to account for any amount included in the
first adjustment. 
 (f) Wire Transfers. All payments to or for the benefit of the Company under this Agreement shall
be in immediately available funds by wire transfer to the account or accounts designated by the Company. 
 Section 3.06 Allocation of
Purchase Price. The Purchase Price and the Assumed Liabilities shall be allocated among the Purchased Assets and the Contributed Assets in accordance with Schedule 3.06. Such allocation shall be binding on Purchaser and the Company for
all purposes, including for federal income Tax purposes and for state and local Tax purposes; provided, however, that the parties acknowledge that the allocation to the Contributed Assets is required by federal law but does not, and is not intended
to, imply a direct purchase of the Contributed Assets by Purchaser. Purchaser and the Company and their respective Affiliates shall report, act upon and file Tax Returns (including, but not limited to, Internal Revenue Service Form 8594) in all
respects and for all purposes consistent with such allocation. Neither Purchaser nor the Company nor any of their Affiliates shall take any position (whether in audits, Tax Returns or otherwise) that is inconsistent with such allocation unless
expressly required to do so by applicable law. 
  

 14 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Section 3.07 Further Assurances. Each of the AG Companies agrees that, at any time and from
time to time on and after the Closing Date, it will, upon the reasonable request of Purchaser and without further consideration, take all steps reasonably necessary to place Purchaser in possession of the Purchased Assets and the LLC in possession
of the Contributed Assets, and each of the AG Companies will do, execute, acknowledge and deliver, or will cause to be done, executed, acknowledged and delivered, all further acts, deeds, assignments, conveyances, transfers, powers of attorney or
assurances as reasonably required to sell, assign, convey, transfer, grant, assure and confirm to Purchaser, or to aid and assist in the collection of or reducing to possession by Purchaser of, all of the Purchased Assets, or to vest in Purchaser
good, valid and marketable title to the Purchased Assets. Purchaser agrees that, at any time and from time to time on and after the Closing Date, upon the reasonable request of the Company and without further consideration, Purchaser will take all
steps reasonably necessary for Purchaser to assume all of the Assumed Liabilities, and execute, acknowledge and deliver all further acts, deeds, assignments, conveyances or transfers reasonably required to assume such Assumed Liabilities. Purchaser
agrees that, at any time and from time to time on and after the Closing Date, it will, upon the reasonable request of the Company and without further consideration, take all steps reasonably necessary to place the Company in possession of the
Excluded Assets (including Discretionary Promotions), and Purchaser will do, execute, acknowledge and deliver, or will cause to be done, executed, acknowledged and delivered, all further acts, deeds, assignments, conveyances, transfers, powers of
attorney or assurances as reasonably required to sell, assign, convey, transfer, grant, assure and confirm to the Company, or to aid and assist in the collection of or reducing to possession by the Company of, all of the Excluded Assets, or to vest
in the Company good, valid and marketable title to the Excluded Assets. 
 Section 3.08 Washington State Taxes. Purchaser and the
Company have jointly submitted to the Washington Department of Revenue a request for an advance ruling that neither Business and Occupation Tax (“B&O Tax”) nor sales or use tax will apply to any of the following transactions:
(a) the Contribution, (b) the sale of all of the interests in the LLC to Purchaser, and (c) the merger of the LLC into Purchaser or the dissolution of the LLC or distribution of the LLC’s assets to Purchaser. Purchaser and the
Company shall promptly apprise each other of the status and inquiries relating to such ruling. Purchaser and the Company each shall use commercially reasonable efforts to obtain a ruling that is favorable to both of them. Following completion of the
Acquisition, the AG Companies and Purchaser will file any and all tax reports and other returns consistent with such ruling. If as a result of such ruling request, (x) [REDACTED] or (y) [REDACTED]. The net amount of the
adjustments described in clauses (x) and (y) above is the “Tax Adjustment.” 
 Section 3.09 Closing. The
closing of the Acquisition (the “Closing”) will take place at 10 a.m., Seattle time, on the date (the “Closing Date”) that is as promptly as practical (but in no event later than the second Business Day) after
satisfaction or waiver of all of the conditions set forth in Article 8 hereof, at the offices of Davis Wright Tremaine LLP, 1201 Third Avenue, Suite 

  

 15 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 2200, Seattle, Washington, 98101 unless another date, time or place is agreed to in writing by Purchaser and the
Company. 
 Section 3.10 Events of Closing. 
 (a) Closing Deliveries by the Company. At the Closing, the Company shall deliver or cause to be delivered to Purchaser: 

(1) An assignment of the LLC Interests in substantially the form attached as Exhibit C, executed by the Company and the LLC;

 (2) A bill of sale in substantially the form attached as Exhibit D, transferring the Purchased Assets to Purchaser,
executed by the Company; 
 (3) One or more assignment and assumption agreements in substantially the form attached as
Exhibit E, executed by the Company; 
 (4) An assignment and assumption of the Norfolk Lease, in substantially the form
attached as Exhibit F, executed by the Company; 
 (5) An intercreditor agreement in substantially the form attached as
Exhibit G, executed by the Company, with respect to collateral securing repayment of Excluded Accounts Receivable and Acquired Receivables; 
 (6) Such other quitclaim deeds, assignments and other instruments of transfer and conveyance, in form and substance sufficient to vest in Purchaser all right, title and interest of the AG Companies in and to the
Purchased Assets, as reasonably requested by Purchaser; and 
 (7) An escrow agreement in substantially the form attached as
Exhibit H, executed by the Company, pursuant to which the Withdrawal Liability Amount will be deposited into escrow. 
 (b) Closing Deliveries by Purchaser. At the Closing, Purchaser shall deliver or cause to be delivered to the Company: 
 (1) The documents described in Section 3.10(a)(1), (3), (4), (5), (6) and (7) executed by Purchaser; and 
 (2) The Closing Payment. 
  

 16 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Article 4 
 Representations And Warranties Of The AG Companies 
 The Company represents and warrants to Purchaser
as follows, except as set forth in the disclosure schedule attached hereto by the Company (the “Company Disclosure Schedule”): 
 Section 4.01 Organization. Each of the AG Companies is a corporation or limited liability company duly organized and validly existing under the Laws of its jurisdiction of organization, has all requisite corporate or limited
liability company power and authority to own, lease, and operate its properties and to carry on its business as now being conducted, and is duly qualified to do business as a foreign corporation and in good standing to conduct business in each
jurisdiction in which the business it is conducting, or the operation, ownership, or leasing of its properties, makes such qualification necessary, other than such failures so to qualify as would not reasonably be expected to have a Material Adverse
Effect. Complete and accurate copies of all Governing Documents of the AG Companies, as in effect as of the Agreement Date, have been made available to Purchaser. 
 Section 4.02 Authority and Enforceability. Each of the AG Companies has all requisite corporate power and authority to enter into this Agreement and to complete the Contemplated Transactions to which it is a
party. The execution, delivery, and performance of this Agreement by each of the AG Companies have been duly authorized by all necessary corporate or limited liability company action on the part of each of the AG Companies, subject to the Company
Shareholder Approval described in Section 8.01(a) hereof. This Agreement has been duly executed and delivered by each of the AG Companies and, subject to the Company Shareholder Approval, and assuming that this Agreement constitutes the valid
and binding agreement of Purchaser, constitutes the valid and binding obligation of the AG Companies, enforceable in accordance with its terms, except as the enforcement hereof may be limited by the Equitable Remedy Exception. 
 Section 4.03 No Violation; Consents. 
 (a) The execution, delivery, and performance of this Agreement by the AG Companies do not conflict with or result in any Violation of (i) any provision of the Governing Documents of any of the AG Companies,
(ii) any Contract to which any of the AG Companies is a party, or (iii) any Laws applicable to any of the AG Companies, except, in the case of clauses (ii) and (iii), for any Violations that would not reasonably be expected have a
Material Adverse Effect. 
 (b) No consent, waiver, approval, order or authorization of, or registration, declaration or
filing with, any Government Agency or other Person (so as not to trigger any Violation) is required by the AG Companies as a result of the execution, delivery, and performance of this Agreement by the AG Companies, except for (i) the filing of
a pre-transaction notification and report form by the Company under the HSR Act, and the expiration 

  

 17 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 or termination of the applicable waiting period thereunder, (ii) such filings and approvals
as may be required by any applicable state takeover, securities or blue sky Laws, (iii) such filings in connection with any state or local Tax which is attributable to the transfer of legal or beneficial ownership of real property, if any, by
any of the AG Companies, (iv) such other filings and consents as may be required under any environmental, health or safety Law pertaining to any notification, disclosure or required approval necessitated by the Acquisition or Contemplated
Transactions, (v) the Company Shareholder Approval, and (vi) such other consents, approvals, orders, authorizations, registrations, declarations, filings, notices or permits that, if they were not obtained or made, would not reasonably be
expected have a Material Adverse Effect. 
 Section 4.04 Financial Statements. 
 (a) Attached to Section 4.04 of the Company Disclosure Schedule are copies of (i) the Company’s audited consolidated
balance sheets at September 29, 2006, September 30, 2005, and September 24, 2004 and the related consolidated statements of operation, shareholder’s equity and cash flows for the fiscal years ended as of such dates (collectively,
the “Company Audited Financial Statements”), and (ii) the June Balance Sheet and the related unaudited consolidated statements of operations and cash flows for the year-to-date fiscal period then ended (collectively, the
“Company Interim Financial Statements” and together with the Company Audited Financial Statements, the “Financial Statements”). 
 (b) The Company Audited Financial Statements, as stated therein and as modified in the notes thereto, and the Company Interim Financial
Statements fairly present, in all material respects, the consolidated financial position of the Company and its consolidated Subsidiaries as of their respective dates and the consolidated results of operations and the consolidated cash flows of the
Company and its consolidated Company Subsidiaries for the periods presented therein, all in conformance with GAAP, applied on a consistent basis during the periods involved (except that the Company Interim Financial Statements do not contain all
footnotes required by GAAP and are condensed and subject to year-end adjustments). 
 (c) The Company has no liability or
obligation (whether absolute, accrued, contingent or other, and whether due or to become due) of a nature required by GAAP to be reflected in a balance sheet or disclosed in the notes thereto, except for (i) liabilities or obligations that are
adequately accrued or reserved against in the June Balance Sheet, (ii) liabilities or obligations that were incurred after the date of the June Balance Sheet in the ordinary course of business consistent with past practice, and
(iii) matters that would not reasonably be expected to have a Material Adverse Effect. 
 Section 4.05 No Material Adverse
Effect. Since the date of the June Balance Sheet through the Agreement Date, there has been no event, occurrence, or condition that has had a Material Adverse Effect, nor has any event, occurrence or condition occurred that would reasonably be
expected, by itself or in conjunction with other events, occurrences or conditions, to have a Material Adverse Effect. 
  

 18 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Section 4.06 No Changes. Since the date of the June Balance Sheet through the Agreement
Date, except as contemplated by this Agreement or the Contemplated Transactions, the Company has not taken any of the actions described in Section 6.02 (Negative Covenants of the Company). 
 Section 4.07 Conduct of the Company Business. Since the date of the June Balance Sheet through the Agreement Date, except as contemplated by this
Agreement or the Contemplated Transactions, and except for such matters that would not reasonably be expected to have a Material Adverse Effect, each of the AG Companies has carried on its business in the ordinary course consistent with past
practice. 
 Section 4.08 Real Property. 
 (a) Owned Real Property. 
 (1) Section 4.08(a)(1) of the Company Disclosure
Schedule lists all real property included in the Purchased Assets that is owned in fee by any of the AG Companies (together with all buildings and other structures, facilities or improvements located thereon, owned by any of the AG Companies, and
all rights and interests appurtenant thereto, the “Owned Real Property”). Complete and accurate copies of all leases of any portion of the Owned Real Property leased to another party (“Fee Property Leases”) listed
in Section 4.08(a)(1) of the Company Disclosure Schedule, including all written amendments and supplements thereof, have been made available to Purchaser. With respect to each such Fee Property Lease, the Company makes each of the
representations set forth in subsections (1), (2), (3), and (4) of Section 4.11(c). Each of the AG Companies owns and has good and marketable title (in each case as measured in the context of their current uses) to the Owned Real Property
owned by it, free and clear of all Liens, except for Permitted Exceptions. 
 (2) To the Company’s Knowledge, except as
disclosed as a special exception listed in Schedule B of the Commitment, (i) all buildings, improvements and structures that are owned by the AG Companies and that are on the Owned Real Property lie within the boundaries of the Owned Real
Property (or within the areas of beneficial easements) and do not encroach upon the property of, or otherwise conflict with the property rights of, any other Person, (ii) the structural components, roofs, and mechanical, electrical, plumbing,
and HVAC systems of the improvements on the Owned Real Property are in good working order and free from defects which would materially impair the use of such improvements for their current uses, ordinary wear and tear excepted, and (iii) all
structures on the Owned Real Property are structurally sound with no known material defects. Except for the Permitted Exceptions, none of the Owned Real Property is subject to any rights of persons in possession or persons making use thereof. Except
as disclosed as a special exception listed in Schedule B of the Commitment, the AG Companies have not received any notice or information that the Owned Real Property or any portion thereof is subject to any claim of adverse possession or
prescriptive easement. 
  

 19 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (b) Leased Real Property. Section 4.08(b) of the Company Disclosure
Schedule lists (i) all real property that is used in the Business and that is leased by any of the AG Companies as tenant pursuant to a Lease included in the Purchased Assets (together with all leasehold improvements thereon, subject to the
terms of the applicable lease agreement (but excluding, common areas, parking spaces and other spaces that the tenant thereunder does not have the exclusive right to use under the applicable lease or under applicable Law), the “Leased Real
Property” and together with the Owned Real Property, the “Real Property”) and (ii) all written leases of Leased Real Property that are included in the Purchased Assets and that are leased by any of the AG Companies as
tenant (“Material Leases”), including all written amendments and supplements thereof. Complete and accurate copies of all Material Leases listed in Section 4.08(b) of the Company Disclosure Schedule have been made available to
Purchaser. With respect to each such Material Lease, the Company makes each of the representations set forth in subsections (1), (2), (3), and (4) of Section 4.11(c). Notwithstanding anything herein to the contrary, the term “Leased
Real Property” excludes the Retail Store or other real property (“Subleased Property”) that any of the AG Companies leases as tenant or subtenant for purposes of subleasing such property to a customer of any of the AG Companies
or otherwise enhancing the credit of the customer or, in some cases, to Persons who are not customers of any of the AG Companies (such subleases being referred to as “Back-to-Back Leases”). The respective AG Companies own and have
good and marketable leasehold (or sub-leasehold) interests (in each case as measured in the context of their current uses) in the Leased Real Property pursuant to the Material Leases, free and clear of all Liens arising by, through or under the AG
Companies, except for the Permitted Exceptions. 
 (c) Loans and Mortgages. Section 4.08(c) of the Company
Disclosure Schedule sets forth, with respect to each person (a “Lender”) holding any mortgage, deed of trust and other lien encumbering the Owned Real Property and included in the Permitted Exceptions (excluding liens for
nondelinquent Taxes) (a “Mortgage”) that secures a loan or obligation (a “Loan”), (i) the outstanding amount of the Loan as of the date of this Agreement, (ii) the date the balance of the Loan will be due
and, assuming all interim payments are made when due, the approximate amount of such balance, (iii) the address to which Purchaser is to give any notices to the Lender, and (viii) the Purchaser’s address to which the Lender shall send
any notices related to the Loan after being notified in writing that this transaction has closed. With respect to each such Mortgage and Loan, (i) to the Company’s Knowledge, the Lender is the sole, current holder thereof, (ii) the
Loan and Mortgage have not been pledged or assigned by any of the AG Companies, (iii) there are no defaults thereunder by the AG Companies, and (iv) Purchaser’s acquisition of the encumbered property will not result in an acceleration
of the Loan or a modification of any Loan terms. 
 Section 4.09 Tangible Property. Except with respect to Real Property and Subleased
Property (as to which the exclusive representations and warranties are set forth in Section 4.08 hereof) and Excluded Assets, and except for Permitted Exceptions, the AG Companies have good and marketable title to, or, in the case of leased or
subleased assets, marketable leasehold interests in (in each case as measured in the context of their current uses), or otherwise have the 

  

 20 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 right to use, all of the tangible assets and properties that are material to the Business, all free and clear of
Liens (except for assets sold or otherwise disposed of, or with respect to which the lease or sublease of such asset has expired or has been terminated, in each case after the Agreement Date to the extent permitted under this Agreement). Each of the
tangible assets and properties that are material to the Business is in good operating condition, subject to the effects of normal wear and tear and subject to the need for normal periodic maintenance. 
 Section 4.10 Intellectual Property Rights. The AG Companies own or possess adequate licenses or other rights to use all Intellectual Property
Rights that are material to the conduct of the Business (“Material IP Rights”). Section 4.10 of the Company Disclosure Schedule contains a list of Material IP Rights that are registered or are pending registration by any of the
AG Companies. To the Company’s Knowledge, such Material IP Rights do not infringe upon the Intellectual Property Rights of others and no other Person is infringing upon the interest of the AG Companies with respect to their Material IP Rights.

 Section 4.11 Material Contracts. 
 (a) Section 4.11 of the Company Disclosure Schedule sets forth a list, as of the Agreement Date, of all Contracts to which any of the AG Companies is a party and that are any of the following (any of the
following, whether or not listed in Section 4.11 of the Company Disclosure Schedules or existing as of the date of this Agreement, a “Material Contract”) (provided that the term Material Contract specifically excludes Material
Leases and Fee Property Leases, as to which the exclusive representations and warranties are set forth in Section 4.08 hereof): 
 (1) A Contract which has not been fully performed and which is for capital expenditures or for the purchase of goods or services in excess of $250,000 per year or for the lease or license of goods in excess of $250,000 per year, if the
Company cannot, at any time, terminate such Contract without penalty and after 90 (or fewer) days notice to the other party or parties. 
 (2) A Contract creating a Lien in excess of $500,000 on any of the AG Companies’ assets, other than Permitted Exceptions. 
 (3) A Contract for the purchase or sale of a material portion of any of the AG Companies’ assets, excluding Contracts for the
purchase or sale of inventory in the ordinary course of business. 
 (4) A Contract with a Government Agency. 
 (5) A Contract which has not been fully performed and which is for the discharge, storage, or removal of Hazardous Materials with fees in
excess of $100,000 per year, if the Company cannot terminate such Contract without penalty and after 90 (or fewer) days notice to the other party or parties. 
  

 21 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (6) A Contract containing covenants not to compete in any business or to provide
favored nations pricing to any Person. 
 (7) A Contract with a supplier where the products purchased under such Contract were
in excess of $1,000,000 during the last 13 consecutive four-week fiscal periods of the Company or where such Contract obligates any of the AG Companies to purchase its requirements from such supplier, in each case if the Company cannot terminate
such Contract without penalty and after 90 (or fewer) days notice to the other party or parties. 
 (8) A Contract between any
of the AG Companies and one of its customers where the products purchased and sold under such Contract were in excess of $1,000,000 during the last 13 consecutive four-week fiscal periods of the Company, if the Company cannot terminate such Contract
without penalty and after 90 (or fewer) days notice to the other party or parties. 
 (9) A Contract granting to any of the AG
Companies rights to purchase and resell private label goods. 
 References in this Section 4.11(a) to a year or fiscal period are to the
year or fiscal period ended on June 8, 2007 (Period 9, 2007). 
 (b) Complete and accurate copies of all written Material
Contracts listed in Section 4.11 of the Company Disclosure Schedule have been made available to Purchaser. 
 (c) With
respect to each Material Contract, as of the Agreement Date: 
 (1) It is the valid and binding obligation of the Company or
the applicable Subsidiary, enforceable against the Company or such Subsidiary in accordance with its terms, subject to the Equitable Remedy Exception. 
 (2) None of the AG Companies is in breach thereof, and to the Company’s Knowledge, no other party thereto is in material breach thereof. 
 (3) To the Company’s Knowledge, no event has occurred or condition exists that constitutes, or with the passage of time would
constitute, a breach by any of the AG Companies. 
 (4) None of the AG Companies has received notice of termination,
cancellation, non-renewal, or material adverse price adjustment thereof. 
 Section 4.12 Compliance with Law. None of the AG Companies
is in violation of, or, to the Company’s Knowledge, is under investigation by any Government Agency with respect to, or has been threatened by any Government Agency to be charged with, or given notice of any violation of, any applicable Law,
except for violations, investigations and charges that would not, singly or in the aggregate, reasonably be expected have a Material Adverse Effect. 
  

 22 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Section 4.13 Material Permits. Except as would not reasonably be expected to have a
Material Adverse Effect, (a) the AG Companies own, hold or possess adequate rights to use all licenses, franchises, permits, certificates, approvals or other similar authorizations that are material to the Business (other than local business
licenses and other immaterial licenses, the “Material Permits”) required in connection with the operation of the Business consistent with past practice, (b) the Material Permits are valid and in full force and effect, and
(c) none of the AG Companies has received any citation, suspension, revocation, limitation, warning or similar notice issued by any Government Agency with respect to its operations or Permits which has not been resolved to the Government
Agency’s satisfaction. A list of such Material Permits is set forth in Section 4.13 of the Company Disclosure Schedule. 
 Section 4.14 Insurance. Set forth in Section 4.14 of the Company Disclosure Schedule is a list of all insurance policies (“Insurance Policies”) covering the assets, business, equipment, properties, operations,
professional liability, and employees of the AG Companies, which list includes the type of coverage, limits of liability, and deductibles. There is no claim by the AG Companies pending under any of such Insurance Policies as to which any of the AG
Companies has received written notice that coverage has been denied or disputed by the underwriters of such Insurance Policies. All premiums due and payable under all such Insurance Policies have been paid. To the Company’s Knowledge, there is
no threatened termination of, or premium increase with respect to, any such Insurance Policies. 
 Section 4.15 Litigation. There is
no suit, action, or similar legal proceeding pending against, or to the Company’s Knowledge, threatened against the AG Companies before any court, arbitrator, or Government Agency, which would , singly or in the aggregate, reasonably be
expected to have a Material Adverse Effect. 
 Section 4.16 Taxes. 
 (a) All Tax returns required to be filed with any taxing authority on or before the Closing with respect to any tax period (or portion
thereof) ending on or before the Closing (a “Pre-Closing Tax Period”) by or on behalf of the AG Companies (collectively “Tax Returns”) have been duly and timely filed (taking into account all applicable extension
periods), and as of the time of filing, such Tax Returns were true and complete in all material respects, in each case, except for matters that would not reasonably be expected to have a Material Adverse Effect. 
 (b) The AG Companies have timely paid or withheld and remitted (or there has been paid or withheld and remitted on their behalf) all Taxes
required to have been paid or withheld on or prior to the Agreement Date (whether or not shown on the Tax Returns), except for Taxes being contested in good faith by appropriate proceedings and for which reserves have been established in the Company
Audited Financial Statements or Company Interim Financial Statements. The Company has made available to Purchaser copies of such Tax Returns filed by the AG Companies since December 31, 1999. 
  

 23 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (c) There is no claim, audit, action, suit, proceeding, or investigation now
pending or, to the Company’s Knowledge, threatened against or in respect of (i) any material Tax or (ii) any material items of net operating loss, net capital loss, investment Tax credit, foreign Tax credit, charitable deduction, or
any other credit or Tax attribute which could be carried forward or back to reduce Taxes. 
 (d) The Company has, at all times
since the formation of the LLC, been its sole member, and no person other than the Company has ever held any direct or beneficial membership interest in the LLC. No election has been made for the LLC to be classified as an association taxable as a
corporation for federal or any other Tax purposes. 
 Section 4.17 Employee Benefits. 
 (a) Section 4.17 of the Company Disclosure Schedule lists each of the following plans (collectively, “Seller Benefit
Plans”) that the AG Companies or any of their ERISA Affiliates sponsor or contribute to or under which the AG Companies or any of their ERISA Affiliates has any liability or contingent liability: (i) any employee welfare benefit plan
or employee pension benefit plan (as those terms are respectively defined in Sections 3(1) and 3(2) of ERISA), including any multi-employer plan (as defined in Section 3(37) of ERISA) and including any plan which has been terminated; or
(ii) any other retirement or deferred compensation plan, incentive compensation plan, stock option plan, stock plan, unemployment compensation plan, vacation pay, severance pay, bonus or benefit arrangement, insurance or hospitalization program
or any other fringe benefit arrangements for any current or former employee, director, consultant or agent, whether pursuant to contract, arrangement, custom or informal understanding. 
 (b) A true and correct copy of each Seller Benefit Plan listed in Section 4.17 of the Company Disclosure Schedule, and all Contracts
relating thereto, or to the funding thereof, including all trust agreements, insurance Contracts, investment management agreements, subscription and participation agreements and record keeping agreements, each as in effect on the Agreement Date, has
been made available to Purchaser. In the case of any Seller Benefit Plan which is not in written form, the Company has provided Purchaser with an accurate description of such plan, arrangement, or agreement as in effect on the Agreement Date. The
Company has made available to Purchaser a true and correct copy of the most recent annual report, actuarial report, summary plan description and IRS determination letter with respect to each such plan or arrangement, to the extent applicable, and a
current audit or schedule of assets (and the fair market value thereof assuming liquidation of any asset which is not readily tradable) held with respect to any funded plan arrangement or agreement. 
 (c) As to all Seller Benefit Plans listed in Section 4.17 of the Company Disclosure Schedule, and except as set forth therein:

 (1) All Seller Benefit Plans comply, and have been administered in form and in operation, in all material respects, in
compliance with their terms and all requirements 
  

 24 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 of Law applicable thereto, and the Company has not received any notice from any Government Agency
questioning or challenging such compliance. 
 (2) Each Seller Benefit Plans which is intended to be a qualified plan under
Sections 401(a) and 501(a) of the Code complies in form and in operation with all applicable requirements of ERISA and such Sections of the Code and has received a determination letter from the IRS stating that it qualifies under such Sections of
the Code, and no event has occurred which will or could give rise to disqualification of any such plan under such Sections or to any Tax imposed by the IRS with respect to such plans. 
 (3) None of the assets of any employee benefit plan is invested in employer securities or employer real property. 
 (4) There have been no prohibited transactions (as described in Section 406 of ERISA or Section 4975 of the Code) with respect
to any employee benefit plan except those for which a statutory exemption is available. 
 (5) As to any employee pension
benefit plan which is subject to Title IV of ERISA, there have been no reportable events (as described in Section 4043 of ERISA), and no steps have been taken to terminate any such plan, and none of the AG Companies has withdrawn from any
multi-employer plan. 
 (6) There have been no acts or omissions by which have given rise to or may give rise to fines,
penalties, taxes, or related charges under Sections 502(c), 502(i) or 4071 of ERISA or Section 4975 through 4980D of the Code. 
 (7) None of the payments contemplated by such plans, arrangements, and agreements would, in the aggregate, constitute excess parachute payments as defined in Section 280G of the Code. 
 (8) There are no IRS or U.S. Department of Labor audits and no actions, suits or claims (other than routine claims for benefits) pending
or threatened involving such plans or the assets of such plans, and no facts exist which could give rise to any such actions, suits or claims (other than routine claims for benefits). 
 (9) All group health plans have been operated in substantial compliance with the group health plan continuation coverage requirements of
Section 4980B of the Code and Section 601 of ERISA to the extent such requirements are applicable, and no group health plan provides benefit coverage subsequent to termination of employment except as required by Section 4980B of the
Code and Section 601 of ERISA or applicable state insurance Laws. 
  

 25 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (10) All required employer contributions and premiums have been timely made, and
all employee contributions and premiums withheld have been timely contributed to the appropriate plan or trust. 
 Section 4.18 Employment
Matters. Section 4.18 of the Company Disclosure Schedule lists, as of the Agreement Date, all employees of the AG Companies (“Business Employees”) and sets forth, with respect to each such employee, his or her (i) job
classification, (ii) salary or wage rate, (iii) employment status, (iv) job location, and (v) union affiliation, if any. 
 Section 4.19 Labor Relations. 
 (a) The Company Disclosure Schedule contains a list of all collective
bargaining agreements to which any of the AG Companies is a party. Except for such agreements, (i) no collective bargaining agreements relating to any of the Business Employees are being negotiated and (ii) no union organizational campaign
or representation petition is currently pending or, to the Company’s Knowledge, threatened with respect to any of the Business Employees. 
 (b) There is no pending or, to the Company’s Knowledge, threatened, strike, slowdown, lock-out, work-stoppage, union organizing effort, or other labor dispute, labor board proceeding, labor arbitration
proceeding, or administrative tribunal proceeding, involving any of the Business Employees. 
 (c) The Company has made
available to Purchaser copies of all certifications, collective agreements, letters of understanding, and any applicable orders of the labor relations board pertaining to a labor organization and which relate to the employment of any of the Business
Employees. 
 (d) (i) To the Company’s Knowledge, there are no complaints filed with any Government Agency by any
Business Employee (including, for purposes hereof, any person who has in the past been employed by any of the AG Companies), against any of the AG Companies claiming that any of the AG Companies has violated any applicable Law or governmental order
relating to employee or civil rights; (ii) there are no complaints or proceedings of any kind involving any of the AG Companies or, to the Company’s Knowledge, by any of the Business Employees, before any labor relations board, including
the National Labor Relations Board; (iii) there are no outstanding orders or charges in respect of any of the Business Employees against any of the AG Companies under any applicable Law or governmental order relating to health and safety; and
(iv) all levies, assessments, and penalties made against any of the AG Companies pursuant to any Law or governmental order providing for workers compensation for any of the Business Employees have been paid by the AG Companies and has been
reassessed under such governmental order during the past five years, except in the case of clauses (i), (ii) and (iii) above, such as would not reasonably be expected to result in a Material Adverse Effect. 
  

 26 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (e) To the Company’s Knowledge, all Business Employees are authorized to work
in the jurisdictions in which they are working according to applicable immigration Laws. 
 (f) There are no actions or legal
proceedings which are pending against any of the AG Companies before any Government Agency, or arbitrator, or, to the Company’s Knowledge, which have been asserted or threatened against any of the AG Companies, in connection with any of the
Business Employees for any of the following, except such actions or legal proceedings that would not reasonably be expected to result in a Material Adverse Effect (i) wages, salaries, commissions, bonuses, vacation pay, severance or termination
pay, sick pay or other compensation; (ii) employee benefits; (iii) alleged unlawful, unfair, wrongful or discriminatory employment or labor practices; (iv) alleged breach of contract or other claim arising under a collective
bargaining agreement, individual agreement, or any other employment covenant whether express or implied; (v) alleged violation of occupational safety and health standards; or (vi) alleged violation of immigration, workers compensation,
disability, unemployment compensation, whistleblower Laws, family and medical leave, or other employment or labor relations Laws. 
 (g) No grievance, arbitration, or other proceeding arising, or asserted to arise, out of or under a collective bargaining agreement, relating to any of the Business Employees (including, for purposes hereof, any person who has in the past
been employed by any of the AG Companies) is pending, except as such grievance, arbitration or other proceeding would not be reasonably expected to result in a Material Adverse Effect. 
 (h) None of the AG Companies is subject to any unsatisfied or pending settlement agreement, conciliation agreement, letter of commitment,
deficiency letter, or consent decree with any of the Business Employees or applicant for employment, labor union or other representative, or any Government Agency or arbitrator relating to claims of unfair labor practices, employment discrimination,
or other claims with respect to employment and labor practices and policies, and no Government Agency, administrative tribunal, or arbitrator has issued a judgment, order, decree, injunction, decision, award, or finding with respect to the
employment and labor practices or policies of any of the AG Companies which would reasonably be expected to result in a Material Adverse Effect. 
 Section 4.20 Environmental Matters. Except for matters that would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect, and solely with respect to the time any Real Property was owned or operated
by any of the AG Companies, and except as disclosed in the environmental assessment reports made available to Purchaser: 
 (a) None of the AG Companies is now, and none have been, in violation of applicable Environmental Laws and, to the Company’s Knowledge, there are no extant conditions that are reasonably expected to constitute such violation in the
future. There are no requests for information pending or, to the Company’s Knowledge, threatened investigations by any Government Agency with respect to past violations of applicable Environmental Laws. 
  

 27 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (b) None of the AG Companies has used, generated, treated, stored, handled,
located, processed, buried, released, spilled, discharged, emitted, leaked, transported, or disposed of wastes arising from or otherwise relating to the Business, including those wastes containing Hazardous Materials (other than motor oil,
antifreeze, propane, household products and other similar items included in inventory sold by AG Companies, or de minimis quantities of such materials used in the operation and maintenance of the Real Property and the Business), in violation
of applicable Environmental Laws (including the filing of any required reports with respect thereto) or environmental Permits. None of the AG Companies has transported or arranged for the transportation of any wastes or Hazardous Materials to any
location which is, as of the Agreement Date, listed on the United States Environmental Protection Agency National Priorities List of Hazardous Waste Sites or other similar list maintained by any Government Agency (such list, together with any
similar state lists, shall be referred to collectively as “National Priorities List”) or listed for possible inclusion on the National Priorities List. 
 (c) None of the AG Companies has received any notice at any time that it or its business as historically conducted is or was claimed to be
in violation of the provisions of any Environmental Law or in violation of the conditions of any environmental Permit, and there is no pending or, to the Company’s Knowledge, threatened action to that effect. 
 (d) There has been no action, suit, claim, arbitration, grievance, or complaint, or any charge, proceeding or investigation commenced by
or pending before any Government Agency against any of the AG Companies under any Environmental Law or otherwise with respect to the handling of any Hazardous Materials. 
 Section 4.21 Customers. Section 4.21 of the Company Disclosure Schedule contains a complete and accurate list of the names and addresses of all customers of the AG Companies as of the Agreement Date. None
of the top 20 customers based on purchases from the AG Companies for the four-week fiscal period ended on the date of the June Balance Sheet has (a) ceased or substantially reduced or changed the terms of its purchases from any of the AG
Companies since the end of such fiscal period or (b) to the Company’s Knowledge, threatened to cease or substantially reduce or change its business with any of the AG Companies, by reason of the Contemplated Transactions or otherwise.

 Section 4.22 Suppliers. Section 4.22 of the Company Disclosure Schedule contains a complete and accurate list of all suppliers
of the AG Companies as of the Agreement Date from whom the AG Companies purchased at least $1,000,000 in products and services in the four-week fiscal period ended on the date of the June Balance Sheet. None of the top 20 suppliers based on volume
of products purchased by the AG Companies for the four-week fiscal period ended on the date of the June Balance Sheet has (a) ceased or substantially reduced or changed the terms of its sales to any of the AG Companies since the end of such
fiscal period or (b) to the Company’s Knowledge, threatened to cease or substantially reduce or change its sales to any of the AG Companies, by reason of the Contemplated Transactions or otherwise. 
  

 28 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Section 4.23 Brokers and Finders Fees. Except as to Piper Jaffray & Co., none of
the AG Companies has incurred, directly or indirectly, any liability for brokerage or finders fees or agents commissions or any similar charges in connection with this Agreement or the Acquisition. 
 Section 4.24 Inventory. The values at which inventories are carried reflect an inventory valuation policy in accordance with GAAP. 
 Section 4.25 Acquired Receivables. All Acquired Receivables represent bona fide transactions of the AG Companies. Except to the extent paid prior
to the Closing Date, and except as enforcement may be limited by the Equitable Remedy Exception, such Acquired Receivables are or will be as of the Closing Date collectible net of the respective reserves shown on the Closing Balance Sheet (which
reserves are adequate and calculated consistent with past practice). To the Company’s Knowledge, there is no contest, claim, defense or right of setoff, other than returns in the ordinary course of business of the AG Companies, under any
contract with any account debtor of any Acquired Receivables relating to the amount or validity of such Acquired Receivables. 
 Section
4.26 Product Warranties; Products Liability. 
 (a) Section 4.26(a) of the Company Disclosure Schedule sets forth the
standard terms and conditions of warranties for, and current policies with respect to returns of, products of each of the AG Companies. 
 (b) There exists no material pending nor, to the Company’s Knowledge, threatened action, suit, inquiry, proceeding or investigation by any person or entity or by or before any governmental body relating to any
product distributed or sold by the AG Companies to third parties, and alleged to have been defective or in breach of any express or implied product warranty. Each of the AG Companies is insured against product liabilities in accordance with the
insurance policies identified in Section 4.14 of the Company Disclosure Schedule, subject to any applicable deductible or retention. 
 Section 4.27 Solvency. None of the AG Companies is insolvent nor will any be rendered insolvent by any of the Contemplated Transactions. As used in this section, “insolvent” means that the sum of the debts and other
probable liabilities of any of the AG Companies exceeds the present fair saleable value of its assets. 
 Section 4.28 WARN Act. Each
of the AG Companies either (i) is not and has not been an “employer” or has not engaged in any “plant closing” or “mass layoff” as such terms are defined in the Worker Adjustment Retraining and Notification Act of
1988, as amended (the “WARN Act”), each within the 90 days prior to the Closing, or (ii) has provided any notification required by the WARN Act or comparable state laws, or satisfied any severance liabilities, payroll sums and
benefit amounts owed due to failure to provide such notice. Section 4.28 of the Company Disclosure Schedule lists all employees that have suffered such an “employment loss” in the 90 days prior to Closing. 
  

 29 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Section 4.29 No Other Representations. The only representations and warranties of the
Company, or with respect to any of the AG Companies, are contained in this Article 4 and the Company Disclosure Schedule. No due diligence or other information or documents given or made available to Purchaser by any of the AG Companies or any other
Person shall be deemed to constitute express or implied representations or warranties. 
 Article 5 
 Representations And Warranties Of Purchaser 
 Purchaser hereby represents and warrants to the Company as follows, except as set forth in the disclosure schedule attached hereto by Purchaser (the “Purchaser Disclosure Schedule”): 
 Section 5.01 Organization. Purchaser is a corporation duly organized, validly existing, and in good standing under the Laws of its jurisdiction of
incorporation, and has all requisite corporate power and authority to own, lease and operate its properties and to carry on its business as now being conducted. 
 Section 5.02 Authority and Enforceability. Purchaser has all requisite corporate power and authority to enter into this Agreement and to complete the Contemplated Transactions. The execution and delivery of
this Agreement and the other agreements contemplated herein and the completion of the Contemplated Transactions have been duly authorized by all necessary corporate action on the part of Purchaser. This Agreement has been duly executed and delivered
by Purchaser, and assuming that this Agreement constitutes the valid and binding agreement of the Company, constitutes the valid and binding obligation of Purchaser, enforceable in accordance with its terms, except as the enforcement hereof may be
limited by the Equitable Remedy Exception. 
 Section 5.03 No Violation. 
 (a) The execution and delivery of this Agreement and the completion of the Contemplated Transactions by Purchaser do not conflict with or
result in any Violation of (i) any provision of the Governing Documents of Purchaser, (ii) except as to which requisite waivers or consents can be obtained by Closing, any material contract to which Purchaser is a party, or (iii) any
Laws applicable to Purchaser, except, in the case of clauses (ii) and (iii), for any Violations that would not reasonably be expected have a Purchaser Material Adverse Effect. 
 (b) No consent, waiver, approval, order or authorization of, or registration, declaration or filing with, any Government Agency or any
other person, including a party to any material contract with Purchaser (so as not to trigger any Violation), is required by or with respect to Purchaser in connection with the execution and delivery of this Agreement or the completion of the
Contemplated Transactions, except for (i) the filing of a pre-merger notification and report form by Purchaser under the HSR Act, and the expiration or termination 

  

 30 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 of the applicable waiting period thereunder, (ii) such filings and approvals as may be
required by any applicable state takeover, securities or blue sky Laws, and (iii) such other consents, approvals, orders, authorizations, registrations, declarations, filings, notices or permits that, if they were not obtained or made, would
not reasonably be expected have a Purchaser Material Adverse Effect. 
 Section 5.04 Brokers and Finders Fees. Except as to Wells
Fargo Securities, LLC and The Food Partners, neither Purchaser nor any of its affiliates has incurred, directly or indirectly, any liability for brokerage or finders fees or agents commissions or any similar charges in connection with this Agreement
or any of the Contemplated Transactions. 
 Section 5.05 Funding. Purchaser has the financial resources to satisfy Purchaser’s
obligations to pay the Closing Payment. Purchaser is not aware of any facts or circumstances that cause Purchaser to believe that it will not, on the Closing Date, have the financial resources necessary to complete the Contemplated Transactions.

 Section 5.06 Litigation. There is no suit, action, or similar legal proceeding pending against, or to Purchaser’s Knowledge,
threatened against Purchaser before any court or arbitrator or any Government Agency, which would reasonably be expected to have a Purchaser Material Adverse Effect. 
 Section 5.07 Due Diligence Investigation. Purchaser and its representatives have been permitted access to books and records, facilities, equipment, tax returns, contracts and agreements, insurance policies (or
summaries thereof), other documents, and other properties and assets of the AG Companies, have been given the opportunity to meet with the officers and employees of the Company and to perform such due diligence investigation and inquiries of the AG
Companies as they have required, and have completed all of their due diligence investigation necessary or desirable for Purchaser to enter into this Agreement. Subject only to the Company’s express representations and warranties contained in
Article 4 above, Purchaser assumes the responsibility and risk of all defects and conditions pertaining to the Real Property, Subleased Property, and other assets of the AG Companies, including such defects and conditions, if any, that cannot be
observed by casual inspection, accepts them in their present “AS IS” condition, and waives and releases all claims against the AG Companies with regard to any condition affecting such property. 
 Notwithstanding any such access, meetings, and discussions, and notwithstanding anything to the contrary, (a) no due diligence materials or other
information or documents shall be deemed to constitute express or implied representations or warranties, and (b) Purchaser acknowledges that it has not received and are not relying upon any representation or warranty, expressed or implied, by
operation of law or otherwise, as to the accuracy or completeness of any information regarding any of the AG Companies or their businesses, results of operations, financial condition, assets, liabilities, or prospects made available to Purchaser or
its representatives except as expressly set forth in Article 4 hereof and in the certificate delivered pursuant to Section 8.02(c). 
  

 31 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Article 6 
 Conduct Prior To The Closing 
 Section 6.01 Affirmative Covenants of the Company. During the
period from the Agreement Date until the Closing or earlier termination of this Agreement, except as expressly contemplated or permitted by this Agreement or to the extent that Purchaser shall otherwise consent in writing, which shall not be
unreasonably withheld, delayed or conditioned, (a) the Company shall, and shall cause each Subsidiary to, carry on the Business in the ordinary course in substantially the same manner as heretofore conducted, and (b) the Company shall, and
shall cause each Subsidiary to, use commercially reasonable efforts to (i) preserve intact its present business organization and goodwill, maintain its rights and franchises, retain the services of its current officers and key employees, and
preserve its relationships with customers, suppliers, and others having business dealings with it, (ii) maintain supplies and inventories in quantities consistent with its customary business practices, (iii) keep in effect insurance
comparable in amount and scope of coverage to the Insurance Policies, and (iv) maintain in effect all existing material Permits. 
 Section 6.02 Negative Covenants of the Company. During the period from the Agreement Date until the Closing or earlier termination of this Agreement, except as expressly contemplated by this Agreement or Section 6.02 of the
Company Disclosure Schedule or to the extent that Purchaser shall otherwise consent in writing, which shall not be unreasonably withheld, delayed or conditioned, the Company shall not do any of the following and shall prohibit any Subsidiary from
doing any of the following: 
 (a) Amend or propose to amend its Governing Documents. 
 (b) (i) Merge, consolidate with, or acquire any equity interest in any corporation, partnership, association or other business
organization, or enter into an agreement with respect thereto, (ii) acquire or agree to acquire any material assets, except for the purchase of inventory and supplies in the ordinary course of business and except for capital expenditures that
are regularly scheduled or that are less than $250,000 individually and $500,000 in the aggregate, or (iii) make any loan or advance to, or otherwise make any investment in, any Person, other than loans or advances to, or investments in, a
Subsidiary (other than in connection with transactions involving real property, which shall require Purchaser’s consent), trade debt or employee advances in the ordinary course of business consistent with past practice. 
 (c) Sell, lease, encumber or otherwise dispose of, or agree to sell, lease (whether such lease is an operating or capital lease), encumber
or otherwise dispose of, any of the Purchased Assets or the Contributed Assets, other than sales of inventory or sales or returns of obsolete or surplus equipment in the ordinary course of business consistent with past practice. 
  

 32 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (d) Authorize, recommend, propose, or announce an intention to adopt a plan of
complete or partial liquidation or dissolution other than as necessary to effect the Contemplated Transactions. 
 (e) Amend
any of the Assumed Plans. 
 (f) (i) Assume or incur any indebtedness for borrowed money (except for draw downs under
existing credit facilities made in the ordinary course of business consistent with past practice), (ii) issue or sell any debt securities or warrants or rights to acquire any debt securities, (iii) guarantee any debt obligations of any
other Person (except obligations of the Subsidiaries in the ordinary course of business (other than in connection with transactions involving real property, which shall require Purchaser’s consent)), or (iv) create any Lien (other than
Permitted Exceptions) on the Purchased Assets or the Contributed Assets or any property of any of the AG Companies subject to a Lease. 
 (g) (i) Enter into, renew or allow for automatic renewal (to the extent automatic renewal could be prevented by giving timely notice) of any Material Contract or (ii) modify, rescind, terminate, waive,
release or otherwise amend in any material respect any of the terms or provisions of any Material Contract. 
 (h) Except as
required by GAAP or applicable Law, make any changes with respect to accounting policies, procedures and practices. 
 (i)
Enter into any legally binding commitment to take any actions prohibited by this Section 6.02. 
 (j) Make or cause to be
made any election for the LLC to be classified as an association taxable as a corporation for federal or any other Tax purposes, or otherwise take any action that would cause the LLC to be classified as a partnership or other business entity for
federal or any other Tax purposes (including, without limitation, causing the LLC to have more than one actual or beneficial member). 
 Section 6.03 Consents. The Company shall use commercially reasonable efforts to obtain such consents, waivers, and approvals under any of the Contracts, Intellectual Property Rights and Permits as are necessary to complete the
Acquisition, including those described in Section 8.01(e), and Purchaser shall cooperate with the Company, including providing such information about Purchaser as parties to Contracts, Intellectual Property Rights and Permits may request.

 Section 6.04 Company Shareholder Approval. The Company shall promptly after the Agreement Date give all required notices and take
all action necessary in accordance with the Washington Business Corporation Act, as codified in title 23B of the Revised Code of Washington (the “WBCA”), and its Governing Documents, (i) to notify the shareholders of a meeting
to seek the Company Shareholder Approval and (ii) to mail to shareholders information 

  

 33 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 relevant to their vote and as required under the WBCA (as such information may amended or supplemented, the
“Company Information Statement”). The Company shall provide Purchaser with the Company Information Statement a sufficient time in advance of its mailing to allow Purchaser to review it and the Company shall review and consider
Purchaser’s comments, if any. The Board of Directors and each of the AG Companies, as applicable, shall 
 (a) promptly
and duly call, give notice of, convene and hold a meeting of its shareholders for the purpose of obtaining the Company Shareholder Approval, 
 (b) recommend approval of the Acquisition and this Agreement and the dissolution of the Company and the plan of dissolution adopted by the Board of Directors of the Company by its shareholders and include in the
Company Information Statement such recommendations, and 
 (c) take all commercially reasonable and lawful action to solicit
and obtain the Company Shareholder Approval, subject to Section 6.09 hereof. 
 Section 6.05 Access to Information. The Company
shall afford to Purchaser and its accountants, counsel, and other representatives reasonable access during the period prior to the Closing to all of the AG Companies’ properties, books, Contracts, Leases, Permits, commitments and records, all
other information concerning the Business, properties and personnel (subject to restrictions imposed by applicable Law) as Purchaser may reasonably request for the purpose of determining actions necessary to complete the Acquisition and to determine
satisfaction of the conditions to Closing set forth in Article 8 hereof. Purchaser shall afford to the Company and its representatives reasonable access during the period prior to the Closing to such information (subject to restrictions imposed by
applicable Law) as the Company may reasonably request for the purposes of determining actions necessary to complete the Acquisition and Purchaser’s plans for supplying the Company’s customers, and to determine satisfaction of the
conditions to Closing set forth in Article 8 hereof. If Purchaser or any of its representatives enters onto any of the Real Property or Subleased Property prior to Closing, they shall do so in a prudent and reasonable manner and so as to not
interfere with the rights or operations of any parties in possession or violate any Permitted Exceptions; Purchaser shall defend, indemnify and hold the AG Companies harmless from any damages, injuries, Liens, losses, expenses (including reasonable
attorneys’ fees) or claims arising from or related to such entry by Purchaser or any of its representatives, and such indemnification and defense obligation shall survive the Closing or earlier termination of this Agreement. 
 Section 6.06 Public Disclosure. No party hereto shall make any disclosure or issue any statement or communication to any third party regarding the
existence or subject matter of this Agreement or the Contemplated Transactions, including, if applicable, the termination of this Agreement and the reasons therefor, without the consent of the Company and Purchaser, which consent shall not be
unreasonably withheld, conditioned, or delayed; provided, however, that (a) Purchaser may make any public disclosure required by applicable securities Law or any listing or trading agreement concerning its publicly traded securities (in
which case the Company 

  

 34 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 shall be entitled to advance review and approval prior to any such disclosure and Purchaser, with respect to any
required Government Agency filings, shall make such confidential treatment requests as are reasonably requested by the Company), (b) the Company may disclose information as necessary or desirable to seek consents or provide notices contemplated
hereunder, including in connection with the Company Shareholder Approval and Section 6.03, Section 6.04, and Section 6.07 hereof, (c) the Company may disclose the information contemplated in Section 6.09 hereof, (d) the
parties may disclose information to such of its legal, accounting, financial, or other advisors or representatives as has a reason to know such information, and (e) the parties will prepare a plan for communications to Business Employees.

 Section 6.07 HSR Compliance. As of the date of this Agreement, Purchaser has concluded that it is not required to file with the
Federal Trade Commission and the Antitrust Division of the Department of Justice a notification under the HSR Act with respect to the Contemplated Transactions. If, based upon changed circumstances, new information and, in the reasonable judgment of
Purchaser, the likelihood that the Closing will occur later than 60 days after the date of this Agreement, Purchaser determines that such a filing is required, Purchaser will promptly so notify the Company. In the event of such notice, Purchaser and
the AG Companies each shall file or cause to be filed with the Federal Trade Commission and the Antitrust Division of the Department of Justice any notification required to be filed by their respective ultimate parent companies under the HSR Act
with respect to the Contemplated Transactions. Such parties will use all reasonable efforts to make such filings promptly after such written notice, and in any case within ten business days thereafter. Purchaser and the AG Companies each agrees to
furnish the other with such information and assistance as the other may reasonably request in connection with its preparation of any filing or submission necessary under the HSR Act. Purchaser and the Company each shall keep the other apprised in a
prompt manner of the status and inquiries or request for additional information from the FTC and the DOJ and shall comply promptly with any such inquiry request. Purchaser and the Company each shall use commercially reasonable efforts to obtain the
termination or expiration of any applicable waiting period required under the HSR Act for the completion of the Contemplated Transactions. 
 Section 6.08 Non-Solicitation. Subject to Section 6.09, after the Agreement Date until the Closing or earlier termination of this Agreement, none of the AG Companies will directly or indirectly solicit a Takeover Proposal; enter
into, continue, or participate in discussions or negotiations regarding a Takeover Proposal; or, except as contemplated herein, furnish to any third party any material nonpublic information to facilitate a Takeover Proposal. Each of the AG Companies
shall, and shall cause its directors, officers or employees or any investment banker, financial advisor, attorney, accountant or other advisor, agent or representative (collectively, “Representatives”) retained by it to, immediately
cease and cause to be terminated all existing discussions or negotiations with any Person conducted heretofore with respect to any Takeover Proposal. Each of the AG Companies agrees it will take the necessary steps to inform promptly its
Representatives of the obligations undertaken in this Section 6.08. “Takeover Proposal” means a bona fide proposal or offer from a Person (other than Purchaser or any of its Affiliates) 

  

 35 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 for a direct or indirect acquisition of all or substantially all of the Purchased Assets and the Contributed
Assets of the AG Companies or a majority of the Class A Common Stock, whether by tender offer, exchange offer, merger, consolidation, or similar transaction, that was not solicited in violation of this Section 6.08. Announcements,
publicity or other disclosures concerning any aspect of this Agreement or the Acquisition, including the existence of this Section 6.08 or the AG Companies’ obligations hereunder, shall not constitute a solicitation in violation of this
Section 6.08, provided that such disclosures were not made in violation of Section 6.06. 
 Section 6.09 Proposals.

 (a) Notwithstanding anything to the contrary, including Section 6.04 and Section 6.08, if (i) the Company
receives a Takeover Proposal and the Company discloses to Purchaser the material terms and conditions of the Takeover Proposal and the identity of the Person making such Takeover Proposal and (ii) the Board of Directors determines that such
Takeover Proposal is or is reasonably likely to lead to a Superior Proposal (after taking into account any written binding offer by Purchaser to improve the terms of this Agreement or the Contemplated Transactions in response to such Takeover
Proposal), the Company and its Representatives may 
 (1) furnish information with respect to any of the AG Companies to the
Person making the Takeover Proposal (and its Representatives) pursuant to a customary confidentiality agreement, and 
 (2)
participate in discussions or negotiations with the Person making the Takeover Proposal (and its Representatives) regarding the Takeover Proposal. 
 (b) The Company agrees that neither the Board of Directors nor any committee thereof shall (i)(A) withdraw (or modify in a manner adverse to Purchaser), or propose to withdraw (or modify in a manner adverse to
Purchaser), the recommendation or declaration of advisability by the Board of Directors or any committee thereof of this Agreement or the Acquisition or (B) recommend, adopt or approve, or propose publicly to recommend, adopt or approve, any
Takeover Proposal or (ii) approve or recommend, or propose to approve or recommend, or allow any of the AG Companies or any of their Representatives to execute or enter into, any letter of intent, memorandum of understanding, agreement in
principle, merger agreement, acquisition agreement, option agreement, joint venture agreement, partnership agreement or other similar agreement constituting or related to any Takeover Proposal (other than a confidentiality agreement pursuant to
Section 6.09(a)(1)). Notwithstanding anything to the contrary, including Section 6.04, 
 (1) the Board of Directors
or any committee thereof may withdraw or modify its recommendation of the Acquisition and this Agreement, withdraw or modify the Company Information Statement, cancel or postpone any meeting of the shareholders, and otherwise communicate with the
shareholders of the Company as the Board of Directors or any 

  

 36 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 committee thereof deems necessary or appropriate, if the Board of Directors or any committee
thereof determines in good faith (after consultation with outside counsel) that it is advisable to do so in order to comply with its duties to the shareholders of the Company under applicable Law; and 
 (2) in response to a Superior Proposal that did not result from a breach of Section 6.08 or this Section 6.09, the Board of
Directors may terminate this Agreement pursuant to Section 9.01(i). Concurrently with or after such termination, the Company may enter into any letter of intent, memorandum of understanding, agreement in principle, merger agreement, acquisition
agreement, option agreement, joint venture agreement, partnership agreement or other similar agreement with respect to such Superior Proposal; 
 provided, however, that the Company shall pay to Purchaser the Termination Fee as provided in Section 9.03. 
 (c) “Superior Proposal” means a Takeover Proposal on terms and conditions which the Board of Directors determines in good faith are (considering such factors as the Board of Directors deems appropriate, including the
likelihood of completion) more favorable to the Company and its shareholders than those set forth in this Agreement. 
 Article 7

 Additional Covenants 
 Section 7.01 Expenses. Whether or not the Acquisition is completed, each party hereto is solely responsible for all fees and expenses that such party incurs in connection with the negotiation and effectuation of the terms and
conditions of this Agreement and the Contemplated Transactions, except with respect to claims for damages incurred as a result of a material breach of this Agreement. Purchaser shall be responsible for paying any escrow fees in connection with the
Contemplated Transactions. 
 Section 7.02 Tax Matters. 
 (a) Wage Reporting. Purchaser and the Company agree to utilize, or to cause their respective Affiliates to utilize, the standard
procedure set forth in Revenue Procedure 2004-53 with respect to wage reporting. 
 (b) Payment of Taxes. To the
fullest extent permitted by Law, the AG Companies shall bear all transfer (including real estate transfer), documentary, sales, use, stamp, registration, real estate excise, and other Taxes and fees incurred in connection with the transfer of the
Purchased Assets under this Agreement or the Contemplated Transactions. The AG Companies shall timely pay the real estate excise taxes arising with respect to the Contemplated Transactions at Closing and shall hold Purchaser harmless from any
liability arising from the AG Companies’ failure to pay such amounts. Purchaser and the AG Companies shall sign and 

  

 37 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 deliver for filing at Closing any real estate excise tax affidavit (including Washington State
Department of Revenue Form 84-00 1 B) required to be filed in connection with the Contemplated Transactions. 
 (c)
Cooperation on Tax Matters. The parties shall cooperate, as and to the extent reasonably requested by the other party, in connection with any audit, litigation or other proceeding with respect to Taxes. Such cooperation shall include the
retention and (upon the other party’s request) the provision of records and information which are reasonably relevant to any such audit, litigation or other proceeding and making employees available on a mutually convenient basis to provide
additional information and explanation of any material provided hereunder. The parties further agree, upon request, that they will use their best efforts to obtain any certificate or other document from any Tax authority or any other person as may
be necessary to mitigate, reduce, or eliminate any Tax that could be imposed (including with respect to the Contemplated Transactions). 
 Section 7.03 Employees.  
 (a) Purchaser shall make an offer of employment to a number of the Business
Employees (including all 25 Business Employees employed at the Sea-Tuk Warehouse who are currently participants in the Washington Meat Industry Pension Trust) at least equal to the minimum number that would be required to receive offers of
employment, and Purchaser shall commit to retain a sufficient number of those Business Employees who accept such offers (other than those who Purchaser terminates for cause) for a sufficient period of time after Closing, to avoid application of the
WARN Act to the termination of employees by the AG Companies in connection with the Contemplated Transactions, and such offer shall be conditioned only on (i) the occurrence of the Closing and (ii) satisfaction of Purchaser’s standard
hiring criteria, including drug testing standards. Any liability or obligation resulting from any failure to comply with the WARN Act, other than Purchaser’s failure to comply with the provisions of this Section 7.03(a), shall be the sole
responsibility of the AG Companies. Purchaser shall provide the Company weekly with information as to the number of Business Employees to whom it has made an offer of employment and the number of those offerees who have satisfied Purchaser’s
standard hiring criteria, including drug testing standards. The Business Employees that Purchaser hires are referred to as the “Hired Employees”. Each Hired Employee who satisfies the eligibility criteria of Purchaser-sponsored
group health plan (the “Health Plan”) shall be immediately eligible to enroll in the Health Plan. Upon proper completion and submission of any required enrollment forms, coverage for the Hired Employees and their eligible dependents
shall be effective on the Hired Employee’s first day of employment. Any waiting period provisions in the Health Plan shall not apply to Hired Employees and their eligible dependents. 
 (b) Each of the AG Companies shall terminate all of the Hired Employees immediately prior to the Closing and shall satisfy all obligations
with respect to accrued salaries and benefits, including accrued sick, vacation and other paid leave. The AG Companies shall pay such terminated employees all amounts due to them within the time periods required, as the 

  

 38 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 case may be, by the terms of any of the items listed in Section 4.17 of the Company
Disclosure Schedule, agreement or applicable law, other than as provided in (c) below. 
 (c) The Company shall assume
responsibility for the provision of required COBRA notices and coverage to all employees of the AG Companies and their ERISA Affiliates who become “M&A qualified beneficiaries,” within the meaning of Treas. Reg. § 1.4980B-9,
Q&A-4(a), with respect to the Contemplated Transactions, and the related COBRA beneficiaries of the M&A qualified beneficiaries; and the Company shall continue to sponsor or maintain a “group health plan” until the AG Companies
cease to have any employees; provided, however, that if the AG Companies and their ERISA Affiliates cease to sponsor or maintain any “group health plan” following the Closing, Purchaser shall assume responsibility for providing such
notices and coverage to the extent required by COBRA, and the Company shall indemnify Purchaser for any cost or liability arising out of or in connection with Purchaser’s assumption of such COBRA liability, including the cost to Purchaser under
any self-insured plan of paid claims not reimbursed by stop-loss insurance less the amount of any premiums paid to Purchaser. 
 (d) With respect to the Washington Meat Industry Pension Trust (the “Multiemployer Plan”), Purchaser agrees to negotiate with the United Food and Commercial Workers Union Local 81 an obligation for Purchaser to contribute
to the Multiemployer Plan, with respect to Hired Employees who are participants in the Multiemployer Plan, contribution base units for each Hired Employee at a rate that is at least substantially the same as the rate at which the Company was
obligated to contribute to the Multiemployer Plan immediately before the Closing Date. Accordingly, the parties intend that ERISA Section 4204 and this paragraph will apply. Unless the Multiemployer Plan waives the obligation to
post bond pursuant to 29 CFR section 4204.11, the Company shall provide, or, alternatively, pay the cost if Purchaser is required to purchase, any bond required by regulations under ERISA Section 4204 by the time required by such
regulations. The Purchaser agrees to execute any request for waiver of the bond that the Company may request. The AG Companies shall remain secondarily liable if the Purchaser withdraws from the Multiemployer Plan in a complete withdrawal
or a partial withdrawal with respect to the operations on or before the end of the fifth plan year beginning after the Closing Date. If Purchaser incurs liability for withdrawing from the Multiemployer Plan in a complete withdrawal or
partial withdrawal on or before the end of the fifth plan year that begins after the Closing Date (such liability, the “Withdrawal Liability”), the Company shall indemnify the Purchaser for such Withdrawal Liability up to the
following amount: (a) the AG Companies’ Withdrawal Liability if a complete withdrawal had occurred on the Closing Date, as estimated by the appropriate plan actuary or administrator for the Multiemployer Plan (the “Withdrawal
Liability Amount”), multiplied by (b) a fraction, the denominator of which shall be the benefits accrued under the Multiemployer Plan by Hired Employees during the five plan years before the plan year in which withdrawal occurs (the
“Withdrawal Liability Measuring Period”), and the numerator of which shall be the benefits accrued under the Multiemployer Plan by such employees while they were employees of the AG Companies during the Withdrawal Liability
Measuring Period, as all such accruals are calculated by the 

  

 39 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Multiemployer Plan, and (c) reduced proportionately if Purchaser incurs only partial
Withdrawal Liability. The Company agrees that the Withdrawal Liability Amount shall be deducted from the Purchase Price and placed in escrow at the Closing to secure the Company’s obligation to indemnify Purchaser for the Withdrawal
Liability. The balance of the funds remaining in escrow, if any, including any interest accrued, will be released to the Company no later than the first day after the end of the fifth plan year that begins after the Closing Date or, if the
Withdrawal Liability for withdrawals during that fifth plan year is zero, as soon as the Multiemployer Plan certifies that Withdrawal Liability in that plan year is zero. The balance of the funds remaining in escrow, if any, including any
interest accrued, shall also be released to the Company at such time as and to the extent the Multiemployer Plan assesses withdrawal liability against the AG Companies rather than the Purchaser for the operations sold to Purchaser.

 (e) The Company shall cooperate with respect to preparation and adoption of any documentation that the Purchaser reasonably
requests to transfer sponsorship of any of the Assumed Plans. 
 Section 7.04 Real Estate Documents. 
 (a) The Company shall obtain and deliver to Purchaser environmental assessment reports with respect to the Owned Real Property, which
reports shall conform to ASTM Standard E 1527-05 for Phase I Environmental Site Assessments (the “Phase I Assessments”). 
 (b) The Company has obtained and delivered to Purchaser preliminary commitments (collectively, the “Commitment”) for owner’s standard coverage ALTA form of title insurance policies for the Owned
Real Property that is included in the Purchased Assets showing the record title to all such Owned Real Property. All costs of the title examination fee, and all other premiums, costs, fees, charges and expenses in connection with each such
owner’s title insurance policy (excluding any endorsements) shall be paid by the Company. In addition, the Company has delivered to Purchaser true and complete copies of all other deeds, leases, mortgages, deeds of trust, certificates of
occupancy, surveys and similar documents, and all amendments thereof, in any AG Companies’ possession with respect to the Real Property. 
 (c) Except with respect to Excluded Assets or Retained Liabilities, the Company shall use commercially reasonable efforts to obtain and deliver to Purchaser estoppel certificates substantially in the form attached as
Exhibit I executed by each landlord from whom any of the AG Companies leases property under a Lease. 
 Section 7.05 SAS 100
Review. No later than 15 days before the Closing Date, the Company shall cause its outside independent auditor (a) to perform a review of the Company balance sheet for the fiscal quarter ended July 6, 2007 pursuant to Statement of
Accounting Standard (SAS) 100 and (b) to deliver the SAS 100 review report to Purchaser. Purchaser shall reimburse the Company at the Closing for the out-of-pocket expenses incurred by the Company in connection with the SAS 100 review, not to
exceed [REDACTED]. 
  

 40 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Section 7.06 Collection of Accounts Receivable. Purchaser will bill customers for
deliveries of inventory that occurred prior to Closing but were not billed prior to Closing, and the amounts thereof shall be Excluded Accounts Receivable. For a period of 90 days after Closing, Purchaser will use commercially reasonable efforts to
collect on behalf of the AG Companies all of the Excluded Accounts Receivable and will remit the full proceeds of such collection efforts to the Company, without set-off, withholding or delay of any kind, (i) daily, with respect to trade
accounts receivable that are Excluded Accounts Receivable and (ii) no later than the end of the 90-day period for other Excluded Accounts Receivable. Purchaser will use at least the same care and effort in collecting the Excluded Accounts
Receivable that Purchaser uses in the collecting its own receivables. Monies that Purchaser receives with respect to an account debtor of any of the AG Companies shall be applied to reduce oldest outstanding Excluded Accounts Receivable with respect
to such account debtor, before applying any monies to any Acquired Receivable, any accounts receivable created after Closing or any other amounts, unless such account debtor specifically designates a particular receivable or the payment is identical
in amount to a particular receivable, in which case the monies received should be applied as directed by the account debtor or to such particular receivable. The Company will reimburse Purchaser for any reasonable out-of-pocket expenses incurred by
Purchaser in its collection efforts if such expenses were approved in advance by the Company. Upon conclusion of the 90-day period, Purchaser will deliver to the Company all information in the care, custody or control of Purchaser concerning its
efforts to collect any Excluded Accounts Receivable that remain unpaid at such time. If, after the 90-day period, Purchaser receives payments for Excluded Accounts Receivable or Discretionary Funds, Purchaser shall remit such amounts to the Company
no less frequently than every 90 days. 
 Section 7.07 Membership in Purchaser. No later than the first anniversary of the Closing
Date, Purchaser will offer shareholders of the Company the opportunity to become members of Purchaser on the standard terms published by Purchaser from time to time, except that the former Company shareholders will be given the option to build their
Class-B requirement by assignment of patronage dividends. 
 Section 7.08 Access to Information; Transition Services. From and after
Closing, Purchaser shall cooperate with the AG Companies and their accountants, counsel, and other representatives and afford to them reasonable access to all properties, books, Contracts, Leases, Permits, commitments and records, all other
information concerning the Business, properties and personnel (subject to restrictions imposed by applicable Law) as they may reasonably request for the purposes relating to this Agreement or the dissolution, winding down and liquidation of the AG
Companies. Purchaser and the Company shall, if necessary, negotiate in good faith a mutually acceptable space and transition services agreement under which Purchaser will provide office space at 3301 South Norfolk Street, Seattle, Washington
and specified services to the Company after the Closing. The AG Companies shall have royalty-free licenses to use their names and marks in connection with their activities in dissolution, winding down and liquidation. 
  

 41 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Article 8 
 Conditions To The Acquisition 
 Section 8.01 Conditions to Each Party’s Obligation to Effect
the Acquisition. The respective obligations of each party to effect the Acquisition shall be subject to the satisfaction on or prior to the Closing Date of the following conditions: 
 (a) Company Shareholder Approval. Both the Acquisition, including this Agreement, and the dissolution of the Company, including the
plan of dissolution adopted by the Board of Directors of the Company, shall have been approved by the shareholders of the Company at a meeting called for such purpose in accordance with the Governing Documents of the Company and applicable Laws
(collectively, the “Company Shareholder Approval”). 
 (b) HSR Act. The waiting period (and any
extension thereof) applicable to the Acquisition under the HSR Act shall have been terminated or shall have expired, and no order or other requirements that would be materially restrictive to the ongoing operations of the business of Purchaser shall
have been placed on the parties in connection therewith. 
 (c) No Restraints. No temporary restraining order,
preliminary or permanent injunction, or other order issued by any court or other Government Agency of competent jurisdiction preventing the completion of the Acquisition shall be in effect. 
 (d) Statutes. No Law shall have been enacted, promulgated, or otherwise issued by any Government Agency with authority to enforce
such Law, which would make completion of the Closing illegal. 
 (e) Required Consents. All consents listed in
Section 8.01(e) of the Company Disclosure Schedule shall have been obtained. 
 Section 8.02 Additional Conditions to the Obligations
of Purchaser. In addition to the conditions in Section 8.01, the obligations of Purchaser to effect the Acquisition shall be subject to the satisfaction at or prior to the Closing of each of the following conditions, any of which may be
waived, solely in writing, and exclusively by Purchaser: 
 (a) Representations and Warranties. The representations and
warranties of the AG Companies contained in Article 4 hereof shall be true and correct as of the Closing Date as though made on that date, and the representations and warranties made as of a specified date earlier than the Closing Date shall have
been true and correct in all respects on and as of such earlier date, except (i) for changes contemplated by this Agreement and (ii) to the extent that such breaches or inaccuracies, in the aggregate, would not reasonably be expected have
a Material Adverse Effect (provided, however, that any representation or warranty that is subject to a materiality or Material Adverse Effect qualification shall not be subject to such qualification for purposes of determining breaches or
inaccuracies of this clause (ii)). 
  

 42 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (b) Covenants. All covenants to be complied with and performed by the
Company on or before the Closing Date shall have been complied with or performed in all material respects. 
 (c) Closing
Certificate of the Company. Purchaser shall have received a certificate executed on behalf of the Company by a duly authorized officer of the Company to the effect, as of the Closing, of Section 8.02(a) and Section 8.02(b) (unless
otherwise waived in accordance with the terms thereof). 
 (d) Certified Resolutions. Purchaser shall have received a
certificate, validly executed by the Secretary of the Company, certifying as to (i) the valid adoption of resolutions of the Board of Directors and the AG Companies’ shareholders approving the Acquisition and this Agreement in accordance
with the Governing Documents and applicable Laws and (ii) the incumbency and signatures of the officers of each of the AG Companies. 
 (e) FIRPTA Affidavit. The Company shall deliver to Purchaser a non-foreign affidavit dated as of the Closing Date, sworn under penalty of perjury and in form and substance required under Treasury Regulations
promulgated under Section 1445 of the Code stating that the Company is not a “foreign person” as defined in Section 1445 of the Code. 
 (f) Aggregate Minimum Annual Committed Purchases of Qualified Retailers. Qualified Retailers shall have entered into supply agreements, in substantially the form attached as Exhibit J or as otherwise
agreed by Purchaser (each, a “Supply Agreement”), with Purchaser (or with the Company and assignable to Purchaser, if approved in writing by Purchaser) that in the aggregate provide for committed annual purchases from Purchaser of
[REDACTED]. 
 (g) Title Insurance Policies. Purchaser shall have received written confirmation from the title
insurance company issuing the Commitment that it is ready, willing and able to issue its fully paid standard ALTA form of owner’s title insurance policy or policies in which Purchaser is named as the sole holder of fee simple title to all of
the Owned Real Property in the aggregate amount [REDACTED] and subject only to the Permitted Exceptions. 
 (h)
Estoppel Certificates. Purchaser shall have received all of the original, executed estoppel certificates from the landlords identified in Section 7.04(c). 
 (i) Phase I Assessments. Purchaser shall have received the Phase I Assessments. 
 (j) Company Member Distributions. Purchaser shall have received a schedule setting forth, for each member of the Company, its name
and the Company’s estimate of the percentage of the Purchase Price the member would be entitled to receive if the Company distributed the Purchase Price as a dividend to its members, without deduction for any rights of set-off the Company may
have with respect to the member. 
  

 43 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Section 8.03 Additional Conditions to the Obligations of the AG Companies. In addition to
the conditions in Section 8.01, the obligations of each of the AG Companies to complete and effect the Acquisition shall be subject to the satisfaction at or prior to the Closing of each of the following conditions, any of which may be waived,
solely in writing, and exclusively by the Company: 
 (a) Representations and Warranties. The representations and
warranties of Purchaser contained in Article 5 hereof shall be true and correct as of the Closing Date as though made on that date, and the representations and warranties made as of a specified date earlier than the Closing Date shall have been true
and correct in all respects on and as of such earlier date, except (i) for changes contemplated by this Agreement and (ii) to the extent that such breaches or inaccuracies, in the aggregate, would not reasonably be expected have a
Purchaser Material Adverse Effect (provided, however, that any representation or warranty that is subject to a materiality or Material Adverse Effect qualification shall not be subject to such qualification for purposes of determining
breaches or inaccuracies of this clause (ii)). 
 (b) Covenants. All covenants to be complied with and performed by
Purchaser on or before the Closing Date shall have been complied with or performed in all material respects. 
 (c) Closing
Certificate of Purchaser. The Company shall have received a certificate executed on behalf of Purchaser, respectively, by a duly authorized officer of Purchaser to the effect, as of the Closing, of Section 8.03(a) and Section 8.03(b)
(unless otherwise waived in accordance with the terms thereof). 
 (d) Certified Resolutions. The Company shall have
received (i) a certificate, validly executed by the Secretary of Purchaser, certifying as to the valid adoption of resolutions of the board of directors of Purchaser approving the Acquisition and this Agreement in accordance with applicable
Laws and the incumbency and (ii) signatures of the officers of Purchaser. 
 (e) Closing Payments. Purchaser shall
have delivered the full amount of the Closing Payment in accordance with Section 3.05 hereof. 
 (f) Aggregate Minimum
Annual Committed Purchases of Qualified Retailers. Qualified Retailers shall have entered into Supply Agreements with Purchaser (or with the Company and assignable to Purchaser) that in the aggregate provide for committed annual purchases from
Purchaser of [REDACTED]. 
 (g) WARN Compliance. The
Company shall not be required to complete the Closing until the earlier of: (i) the 61st day after the Agreement Date or (ii) the date on which a
sufficient number of Business Employees offered employment by Purchaser have met Purchaser’s standard hiring criteria to avoid any liabilities or obligations of the AG Companies under the WARN Act or comparable state Laws. 
  

 44 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Article 9 
 Termination, Amendment And Waiver 
 Section 9.01 Termination. Subject to Section 9.02,
this Agreement may be terminated and the Acquisition abandoned at any time prior to the Closing only by written notice in one of the following circumstances: 
 (a) By mutual written agreement of the Company and Purchaser. 
 (b) By Purchaser or the Company if the Closing shall not have occurred by October 5, 2007; provided, however, that a party
shall not be entitled to give such notice if it is in material breach of any of its obligations under this Agreement. 
 (c)
By Purchaser or the Company if (i) there shall be a final non-appealable order of a federal or state court in effect preventing completion of the Acquisition or (ii) there shall be any Law enacted, promulgated or issued or deemed
applicable to the Acquisition by any Government Agency with authority to enforce such Law, which would make completion of the Acquisition illegal. 
 (d) By Purchaser if (i) Purchaser is not in material breach of its obligations under this Agreement, (ii) all other conditions to close set forth in Section 8.01 and
Section 8.03(a)-Section 8.03(d) have been satisfied or waived as of the date of termination of this Agreement (or are to be satisfied or waived at Closing), and (iii) there has been a material breach of any representation, warranty,
covenant or agreement of the Company contained in this Agreement such that the conditions set forth in Section 8.02(a) or Section 8.02(b) would not be satisfied and such breach has not been cured within ten calendar days after written
notice thereof to the Company; provided, however, that no cure period shall be required for a breach which by its nature cannot be cured. 
 (e) By the Company if (i) the Company is not in material breach of its obligations under this Agreement, (ii) all other conditions to close set forth in Section 8.01 and Section 8.02 have been
satisfied or waived as of the date of termination of this Agreement (or are to be satisfied or waived at Closing), and (iii) there has been a material breach of any representation, warranty, covenant or agreement of Purchaser contained in this
Agreement such that the conditions set forth in Section 8.03(a) or Section 8.03(b) would not be satisfied and such breach has not been cured within ten calendar days after written notice thereof to Purchaser; provided, however, that
no cure period shall be required for a breach which by its nature cannot be cured. 
 (f) By Purchaser if the Board of
Directors has, in either case adversely to Purchaser, withdrawn or modified its recommendation of the Acquisition and this Agreement, withdrawn the Company Information Statement or cancelled the meeting at which the Company Shareholder Approval was
to have been sought. 
  

 45 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (g) By Purchaser if a tender offer or exchange offer relating to the Class A
Common Stock shall have been commenced by a party other than Purchaser or any of its Affiliates and the Company shall not have promptly thereafter sent its shareholders a statement recommending rejection of the tender offer or exchange offer.

 (h) By the Company, to the extent permitted by Section 6.09(b)(2), if at any time before the Closing all of the
following conditions are met: 
 (1) the Board of Directors authorizes the Company to enter into a binding written agreement
concerning a transaction that constitutes a Superior Proposal and the Company notifies Purchaser in writing that it intends to enter into such an agreement, attaching a summary of the material terms thereof; and 
 (2) Purchaser does not make, within five business days after the receipt of the Company’s written notification of its intention to
enter into a binding agreement for a Superior Proposal, a written offer that the Board of Directors determines, in good faith consistent with its fiduciary obligations under applicable Law after consultation with its legal counsel and financial
advisor, is at least as favorable (taking into account the terms and conditions of the offer and this Agreement and the interests of the Company and its shareholders) as the Superior Proposal. 
 Section 9.02 Effect of Termination. In the event of termination of this Agreement as provided in Section 9.01 hereof, this Agreement shall
forthwith become void and there shall be no liability or obligation on the part of Purchaser or the AG Companies, or their respective officers, directors or shareholders; provided, however, that the provisions of Section 6.06,
Section 7.01, Section 9.03, Article 10 and this Section 9.02, shall survive any termination of this Agreement. 
 Section
9.03 Termination Fee. The Company agrees to pay Purchaser (provided that Purchaser is not then in material breach of any representation, warranty, covenant or agreement contained in this Agreement) by wire transfer, in the case of
(a) below, on the date of entering into or execution of any agreement relating to a Takeover Proposal and, in the case of (b) below, concurrently with such termination, the sum of [REDACTED], in immediately available funds (the
“Termination Fee”) in the event that any of the following shall have occurred: 
 (a) this Agreement shall
have been terminated by Purchaser pursuant to Section 9.01(f) or (g) and, within 12 months after the termination, the Company enters into or executes any agreement relating to a Takeover Proposal (other than a confidentiality agreement
pursuant to Section 6.09(a)(1)); or 
 (b) this Agreement shall have been terminated by the Company pursuant to
Section 9.01(h). 
  

 46 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Section 9.04 Amendment. This Agreement may be amended by the parties hereto at any time
prior to the Closing by execution of an instrument in writing signed on behalf of each of the parties hereto. 
 Section 9.05 Extension;
Waiver. At any time prior to the Closing, Purchaser, on the one hand, and the Company on the other hand, may, to the extent legally allowed, (a) extend the time for the performance of any of the obligations of the other party hereto,
(b) waive any inaccuracies in the representations and warranties made to such party contained herein or in any document delivered pursuant hereto, and (c) waive compliance with any of the agreements or conditions for the benefit of such
party contained herein. Any agreement on the part of a party hereto to any such extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of such party. 
 Article 10 
 General Provisions 
 Section 10.01 Survival and Exclusive Remedies. 
 (a) All representations and warranties made by or on behalf of the AG Companies in or in connection with this Agreement shall expire and be terminated and extinguished, and shall not form the basis for any claim by
Purchaser against any AG Company, as of the Closing; the Withdrawal Liability shall expire and be terminated and extinguished as provided in Section 10.01(e); and the COBRA Liability shall expire and be terminated and extinguished upon
expiration of Purchaser’s statutory obligations for complying with COBRA for the Company’s M&A qualified beneficiaries, except to the extent of Company’s indemnity as set forth in Section 7.03(c). All other liabilities or
obligations of the AG Companies in or in connection with this Agreement shall continue for a period of 180 days after the Closing Date, at which time all such liabilities and obligations shall expire and terminate and shall not form the basis for
any claim by Purchaser against any AG Company; provided, however, that if Purchaser notifies the Company of a claim against any AG Company for a breach of such an obligation before expiration of the 180-day period (a “Claim
Notice”), the obligations set forth in the Claim Notice shall survive solely for the purpose of resolving the claim. 
 (b) At or before Closing, the exclusive remedy available to Purchaser with respect to claims in connection with this Agreement or the Contemplated Transactions will be one of the following, at the election of Purchaser: (i) termination
of this Agreement under Section 9.01 and if applicable, payment of the Termination Fee or (ii) specific performance under Section 10.06 of the Company’s obligation to close the Acquisition on the terms and conditions set forth
herein. 
 (c) Except with respect to the Withdrawal Liability, COBRA Liability, and adjustment to the Purchase Price pursuant
to Section 3.05 after Closing, the exclusive remedy 
  

 47 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 available to Purchaser with respect to claims in connection with this Agreement or the
Contemplated Transactions will be one of the following, at the election of Purchaser: (i) recovery for Losses resulting from the breach of this Agreement by the AG Companies, subject to the limitations in Section 10.01(d) or
(ii) specific performance under Section 11.06, if applicable. Subject to the limitations set forth in Section 10.01(e), the exclusive remedy for the Withdrawal Liability is as set forth in Section 7.03(d). The exclusive remedy
for COBRA Liability is as set forth in Section 7.03(c). 
 (d) Purchaser shall have no claim for any Losses unless all
Losses collectively set forth in Claim Notices hereunder exceed $100,000 (the “Deductible”), and then Purchaser’s only claims shall be for such damages that exceed the Deductible; and the maximum amount that Purchaser may
recover with respect to Losses in connection with this Agreement or the Contemplated Transactions shall be limited to $1,000,000 (the “Cap”); provided, however, that the Deductible and Cap shall not apply to a breach by the
AG Companies of their obligations to deliver to the LLC the Contributed Assets or to deliver to Purchaser the Purchased Assets, COBRA Liability (which is governed exclusively by Section 7.03(c)), Withdrawal Liability (which is governed
exclusively by Section 7.03(d) and Section 10.01(e)), or claims for fraud or intentional misrepresentation. 
 (e)
The maximum amount Purchaser may recover with respect to the Withdrawal Liability is the Withdrawal Liability Amount and no claim may be made with respect to the Withdrawal Liability after the close of the fifth plan year of the Multiemployer Plan
that starts after the Closing Date, except as otherwise provided in the escrow agreement delivered at the Closing. 
 Section 10.02
Notices. All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally or by commercial messenger or courier service, or mailed by registered or certified mail (return receipt requested) or
sent via facsimile (with acknowledgment of complete transmission) to the parties at the following addresses (or at such other address for a party as shall be specified by like notice); provided, however, that notices sent by mail will not be
deemed given until received: 
 If to any of the AG Companies, to:    Associated Grocers, Incorporated 
 3301 S. Norfolk Street 
 Seattle, WA 98118 
 Attn: Vice President, Legal 
 Telephone No.: (206) 767-8813 
 Facsimile No.: (206) 767-8751 
 And with additional copies to:    Davis Wright
Tremaine LLP 
 1201 Third Avenue, Suite 2200 
 Seattle, WA 98101 
 Attn: John A. Reed 
 Telephone No.: (206) 622-3150 
  

 48 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Facsimile No.: (206) 757-7700 
 If to Purchaser,
to:                        Unified Western Grocers, Inc. 
 5200 Sheila Street 
 Commerce, CA 90040 
 Attn: Robert M. Ling, Jr. 
 Telephone No.: (323) 264-5200 
 Facsimile No.: (323) 265-3716 
 With a copy
to:                        Stoel Rives LLP 
 900 SW Fifth Avenue 
 Suite 2600 
 Portland, OR 97204-1268 
 Attn: Robert J. Moorman 
 Telephone No.: (503) 224-3380 
 Facsimile No.: (503) 220-2480 
 Section 10.03 Disclosure Schedules. The Company has arranged the Company Disclosure Schedule in sections corresponding to the numbered and
lettered sections contained in Articles 4, 6, and 8 hereof. Purchaser has arranged the Purchaser Disclosure Schedule in sections corresponding to the numbered and lettered sections contained in Article 5 hereof. The Company shall have the right, at
Closing or at any time before Closing, to deliver to Purchaser one or more certificates which supplement the Company Disclosure Schedule (the “Additional Disclosures”), which Additional Disclosures shall be limited to events or
matters that arise or otherwise occur after the Agreement Date, but not as a result of a material breach by the Company of any of its covenants or agreements contained herein. With respect to any Additional Disclosure, Purchaser may refuse to
complete the Acquisition only if an event or matter disclosed in such Additional Disclosure has had or would reasonably be expected to have, singly or in the aggregate, a Material Adverse Effect that causes the condition in Section 8.02(a)
hereof (with respect to certain breaches of the representations and warranties of the Company) not to be satisfied as of the Closing Date. Disclosure of any fact or item in the Company Disclosure Schedule or any Additional Disclosure shall not
necessarily mean that such item or fact, individually or in the aggregate, is material or adverse to the business, results of operations, or financial condition of any of the AG Companies, or that such item or fact has had or is expected to have a
Material Adverse Effect. Nothing in this Section shall be interpreted as an extension of the survival of any representation or warranty beyond the Closing. 
 Section 10.04 Entire Agreement; No Assignment; No Third Party Beneficiaries. This Agreement, the Exhibits hereto, the Company Disclosure Schedule, the Purchaser Disclosure Schedule, and the documents and
instruments and other agreements among the parties hereto referenced herein (a) constitute the entire agreement among the parties with respect to the subject matter hereof and supersede all prior agreements and understandings both written and
oral, among the parties with respect to the subject matter hereof, (b) shall not be assigned by 

  

 49 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 operation of Law or otherwise, and (c) shall be binding upon and inure solely to the benefit of each party
hereto, and nothing in herein or therein, express or implied, is intended to or shall confer upon any other person any other right, benefit or remedy of any nature whatsoever under or by reason of this Agreement. 
 Section 10.05 Severability. In the event that any provision of this Agreement or the application thereof, becomes or is declared by a court of
competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other persons or circumstances will be interpreted so as reasonably to
effect the intent of the parties hereto. 
 Section 10.06 Specific Performance. The parties recognize that, in the event that a party
should refuse to perform any provisions of this Agreement, monetary damages alone will not be adequate. The parties shall therefore be entitled, in addition to any other remedies that may be available, including money damages, to obtain specific
performance of the terms of this Agreement. In the event of any action to enforce this Agreement specifically, all of the parties hereby waive the defense that there is an adequate remedy at Law and any requirement for bond or other security in
connection therewith. 
 Section 10.07 Waiver of Jury Trial. The parties hereby waive any right to trial by jury in any proceeding
arising out of or relating to this agreement or any of the contemplated transactions, whether now existing or hereafter arising, and whether sounding in contract, tort or otherwise. The parties agree that any of them may file a copy of this section
with any court as written evidence of the knowing, voluntary and bargained-for agreement among the parties irrevocably to waive trial by jury and that any proceeding whatsoever between them relating to this agreement or any of the contemplated
transactions shall instead be tried in a court of competent jurisdiction by a judge sitting without a jury. 
 Section 10.08 Governing
Law; Venue. This Agreement shall be governed by and construed in accordance with the Laws of the State of Washington, regardless of the Laws that might otherwise govern under applicable principles of conflicts of Laws thereof. Each of the
parties hereto irrevocably consents to the exclusive jurisdiction and venue of any court within Seattle, King County, Washington, in connection with any matter based upon or arising out of this Agreement or the matters contemplated herein, agrees
that process may be served upon them in any manner authorized by the Laws of the State of Washington for such persons and waives and covenants not to assert or plead any objection which they might otherwise have to such jurisdiction, venue and such
process. 
 Section 10.09 No Personal Liability. Purchaser acknowledges that the AG Companies and their respective shareholders,
directors, officers, employees, agents, attorneys and representatives (“AG Parties”) have performed, or may perform, acts in connection with this Agreement on behalf of the AG Companies and AG Parties, or on behalf of Purchaser, to
facilitate the Acquisition and the Contemplated Transactions. Notwithstanding anything to the contrary, no such AG Party shall have, as a result of serving in such capacity, and Purchaser 

  

 50 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 hereby absolves all AG Parties from, any personal liability or obligation for any matter relating to or arising
out of this Agreement, the Acquisition, or the Contemplated Transactions. Each of the AG Companies acknowledges that Purchaser and its shareholders, directors, officers, employees, agents, attorneys and representatives (“Purchaser
Parties”) have performed, or may perform, acts in connection with this Agreement on behalf of Purchaser and Purchaser Parties, or on behalf of the AG Companies, to facilitate the Acquisition and the Contemplated Transactions.
Notwithstanding anything to the contrary, no such Purchaser Party shall have, as a result of serving in such capacity, and each of the AG Companies hereby absolves all Purchaser Parties from, any personal liability or obligation for any matter
relating to or arising out of this Agreement, the Acquisition, or the Contemplated Transactions. 
 Section 10.10 Counterparts. This
Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other party, it
being understood that all parties need not sign the same counterpart. Facsimile transmission (or other electronic transmission including email of a PDF signature) of any signed original document, and retransmission of any signed facsimile
transmission, shall be the same as delivery of an original. At the request of any party, the parties will confirm facsimile transmitted (or other electronic transmission including email of a PDF signature) signatures by signing an original document.

 Section 10.11 Attorneys’ Fees. If suit or action is filed by any part to enforce the provisions of the Agreement or otherwise
with respect to the subject matter of this Agreement, the prevailing party will be entitled to recover attorneys’ fees as fixed by final order of the trial court and, if any appeal is taken from the decision of the trial court, attorneys’
fees as fixed by final order of the trial or appellate court, as applicable. 
 [Remainder of page intentionally left blank.]

  

 51 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Each party has caused this Asset Purchase Agreement to be duly executed by its duly authorized
officer or representative on the date first above written. 
  

									
	PURCHASER:	 		 	UNIFIED WESTERN GROCERS, INC.
					
		 		 		 	By	 	/S/    ALFRED A. PLAMANN        

		 		 		 	Name	 	Alfred A. Plamann
		 		 		 	Title	 	President and Chief Executive Officer
			
	THE COMPANY:	 		 	ASSOCIATED GROCERS, INCORPORATED
					
		 		 		 	By	 	/S/    JOHN S.
RUNYAN        
		 		 		 	Name	 	John S. Runyan
		 		 		 	Title	 	President and Chief Executive Officer
			
	AG SUBSIDIARIES:	 		 	SUPERMARKET DEVELOPMENT CORPORATION
					
		 		 		 	By	 	/S/    JOHN S.
RUNYAN        
		 		 		 	Name	 	John S. Runyan
		 		 		 	Title	 	President
			
		 		 	 MARKET FINANCE COMPANY

					
		 		 		 	By	 	/S/    JOHN S.
RUNYAN        
		 		 		 	Name	 	John S. Runyan
		 		 		 	Title	 	President

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
  

									
			
		 		 	MFC CAPITAL-I, LTD.
					
		 		 		 	By	 	/S/    JOHN S.
RUNYAN        
		 		 		 	Name	 	John S. Runyan
		 		 		 	Title	 	President
			
		 		 	MFC 2002, LLC
					
		 		 		 	By	 	/S/    JOHN S.
RUNYAN        
		 		 		 	Name	 	John S. Runyan
		 		 		 	Title	 	Manager
			
		 		 	AGIC INSURANCE AGENCY, INC.
					
		 		 		 	By	 	/S/    JOHN S.
RUNYAN        
		 		 		 	Name	 	John S. Runyan
		 		 		 	Title	 	President
			
		 		 	MARKET INDUSTRIAL RELATIONS SERVICES, INC.
					
		 		 		 	By	 	/S/    JOHN S.
RUNYAN        
		 		 		 	Name	 	John S. Runyan
		 		 		 	Title	 	President
			
		 		 	MARKET SALES, INC.
					
		 		 		 	By	 	/S/    JOHN S.
RUNYAN        
		 		 		 	Name	 	John S. Runyan
		 		 		 	Title	 	President

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
  

									
			
		 		 	SEA-PAC FREIGHT LINES, INC.
					
		 		 		 	By	 	/S/    JOHN S.
RUNYAN        
		 		 		 	Name	 	John S. Runyan
		 		 		 	Title	 	President
			
		 		 	 SUPERMARKET MANAGEMENT CORPORATION

					
		 		 		 	By	 	/S/    JOHN S.
RUNYAN        
		 		 		 	Name	 	John S. Runyan
		 		 		 	Title	 	President
			
		 		 	RED APPLE STORES, INC.
					
		 		 		 	By	 	/S/    JOHN S.
RUNYAN        
		 		 		 	Name	 	John S. Runyan
		 		 		 	Title	 	President
			
		 		 	THRIFTWAY STORES, INC.
					
		 		 		 	By	 	/S/    JOHN S.
RUNYAN        
		 		 		 	Name	 	John S. Runyan
		 		 		 	Title	 	President
			
		 		 	AU DROPDOWN LLC
		 		 		 	By:	 	Its sole member, ASSOCIATED GROCERS, INCORPORATED
					
		 		 		 	By	 	/S/    JOHN S.
RUNYAN        
		 		 		 	Name	 	John S. Runyan
		 		 		 	Title	 	President and Chief Executive Officer

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 EXHIBIT A 
 Definitions 
 Acquired Receivables is defined in Section 3.01(g).

 Acquisition is defined in the Recitals. 
 Additional Disclosures is defined in Section 10.03. 
 Affiliate means, with respect to
any Person, any other Person that directly, or through one or more intermediaries, controls or is controlled by or is under common control with such first Person, and, if an individual, any member of the immediate family (including parents, spouse
and children) of such individual. As used in this definition, control (including, with correlative meanings, controlled by and under common control with) shall mean possession, directly or indirectly, of power to direct or cause the direction of
management or policies (whether through ownership of securities or partnership or other ownership interests, by Contract or otherwise). 
 AG Companies is defined in the introductory paragraph of this Agreement. 
 Agreement Date means the date of this
Agreement, as set forth on the first page of this Agreement. 
 Arbitrator is defined in Section 3.05(c)(2)(i). 
 Assumed Liabilities is defined in Section 3.03. 
 Assumed Plans is defined in Section 3.03(d). 
 Back-to-Back Leases is defined in
Section 4.08(b). 
 Board of Directors means the board of directors of the each of the AG Companies. 
 [REDACTED] 
 Brown and Cole
Litigation is defined in Section 3.02(i). 
 Business is defined in Section 3.01. 
 Business Day means any day, other than a Saturday or Sunday, on which commercial banks and foreign exchange markets are open for business in
Seattle, Washington. 
  

 A-1 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Business Employees is defined in Section 4.18. 
 Claim Notice is defined in Section 10.1. 
 Class A Common Stock means the Class A Voting Common Stock, no stated par value, of the Company. 
 Closing is defined in Section 3.09. 
 Closing Balance Sheet is defined in Section 3.03(a). 
 Closing Date is defined in Section 3.09. 
 Closing Payment is defined in Section 3.05(a). 
 Closing Purchased Working Capital means
Purchased Working Capital as shown on the Closing Balance Sheet. 
 Closing Reserves means the Reserves as of the Closing Date

 COBRA means Section 4980B of the Code and Part 6 of Title I of ERISA, and the regulations promulgated thereunder. 

Code means the Internal Revenue Code of 1986, as amended, and the Treasury regulations promulgated thereunder. 
 Commitment is defined in Section 7.04(b). 
 Company is defined in the introductory paragraph of this Agreement. 
 Company Audited Financial
Statements is defined in Section 4.04(a). 
 Company Disclosure Schedule is defined in the introductory paragraph of Article
4. 
 Company Information Statement is defined in Section 6.04. 
 Company Interim Financial Statements is defined in Section 4.04(a). 
 Company Shareholder Approval is defined in Section 8.01(a). 
 Company’s Knowledge means the actual knowledge of the individuals listed on attached Exhibit K in their capacity as employees of the AG Companies, and without any duty of inquiry or investigation.

 Contemplated Transactions means the Acquisition and the other transactions 

  

 A-2 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 contemplated by this Agreement. 
 Contracts is defined in Section 3.01(c). 
 Contributed Assets is defined in
Section 2.01. 
 Discretionary Funds is defined in Section 3.02(g). 
 Dispute Notice is defined in Section 3.05(c)(2)(i). 
 Environmental Law means any Law relating to the environment, health, safety or Hazardous Materials, including the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended; the
Resource Conservation and Recovery Act of 1986 and Hazardous and Solid Waste Amendments of 1984, 42 U.S.C. §§ 6901 et seq.; the Hazardous Materials Transportation Act, 49 U.S.C. §§ 6901 et seq.; the Clean Water Act, 33 U.S.C.
§§ 1251 et seq.; the Toxic Substances Control Act of 1976, 15 U.S.C. §§ 2601 et seq.; the Clean Air Act of 1966, as amended, 42 U.S.C. §§ 7401 et seq.; the Safe Drinking Water Act, 42 U.S.C. §§ 300f et seq.;
the Atomic Energy Act, 42 U.S.C. §§ 2011 et seq.; the Federal Insecticide, Fungicide and Rodenticide Act, 7 U.S.C. §§ 136 et seq.; the Emergency Planning and Community Right-to-Know Act of 1986, 42 U.S.C. §§ 1101 et
seq.; and the Washington Model Toxics Control Act, RCW Ch. 70.105D. 
 Equitable Remedy Exception means applicable bankruptcy,
insolvency, reorganization, moratorium, fraudulent conveyance or other similar Laws now or hereafter in effect relating to creditors rights generally and general principles of equity (regardless of whether enforceability is considered in a
proceeding at Law or in equity). 
 ERISA means Employee Retirement Income Security Act of 1974, as amended. 
 ERISA Affiliate means any entity that would be deemed a “single employer” with any of the AG Companies under Section 414(b), (c),
(m) or (o) of the Code or Section 4001 of ERISA. 
 Estimated Closing Purchased Working Capital means the Estimated
Purchased Working Capital as of the Closing Date, as estimated by the Company and shown on the Statement of Estimated Closing Purchased Working Capital. 
 Estimated Closing Reserves means the Reserves established as of the Closing Date as shown on the Statement of Estimated Closing Reserves. 
 Excluded Accounts Receivable is defined in Section 3.02(f). 
 Excluded Assets is defined in Section 3.02. 
 Fee Property Leases is defined in
Section 4.08(a)(1). 
  

 A-3 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Financial Statements is defined in Section 4.04(a). 
 GAAP means U.S. generally accepted accounting principles consistently applied. 
 Governing Documents means articles of incorporation, bylaws, certificate of formation, limited liability company or limited partnership agreement,
or similar governing documents of an entity. 
 Government Agency means any Federal, state or local government or any foreign,
national, provincial, or local government, or any governmental, regulatory, legislative, executive, or administrative authority, agency or commission, or any court, tribunal, or judicial body. 
 Hazardous Material means (i) any dangerous, toxic or hazardous pollutant, contaminant, chemical, waste, material or substance as defined in
or governed by any Environmental Law, including any pollutant, contaminant, chemical, waste, material or substance that might cause any injury to human health or safety or to the environment or that might subject any of the AG Companies to any
imposition of costs or liability under any Environmental Law, (ii) petroleum, petroleum hydrocarbons, benzene, toluene, lead, polynuclear aromatics and other products based on or derived from petroleum, and (iii) lead paint, radon above
permissible background levels and PCBs. 
 Hired Employees is defined in Section 7.03(a). 
 Holdback Amount is defined in Section 3.05(a). 
 HSR Act means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder. 
 Insurance Policies is defined in Section 4.14. 
 Intellectual Property is defined in Section 3.01(d). 
 Intellectual Property Rights is
defined in Section 3.01(e). 
 Inventory is defined in Section 2.01(b). 
 IRS means the Internal Revenue Service. 
 January Balance Sheet means the Company’s balance sheet as of January 19, 2007, as restated. 
 Joint
Venture means any entity in which any of the AG Companies has an equity, voting or participation interest other than the Subsidiaries. 
 June Balance Sheet means the Company’s balance sheet as of June 8, 2007. 
  

 A-4 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Law means any judgment, order, decree, statute, law, ordinance, rule, regulation, writ, or
injunction. 
 Leased Real Property is defined in Section 4.08(b). 
 Leases is defined in Section 3.01(b). 
 Liens means any and all pledges, liens, charges, security interests, restrictions, or other encumbrances of any kind. 
 Lender is defined in Section 4.08(c). 
 LLC means AU Dropdown LLC. 
 LLC Interests means all of the membership interests of the LLC. 
 Loan is defined in Section 4.08(c). 
 Long Term Asset Adjustment is defined in Section
3.05(b)(3). 
 Losses means actual out-of-pocket losses, damages, debts, liabilities, obligations, judgments, orders, awards, writs,
injunctions, decrees, fines, Taxes, costs or expenses (including reasonable attorney’s fees or expenses). 
 Material Adverse
Effect means the result of an event, occurrence, or condition that, individually or in the aggregate, either (i) is a material adverse effect on the consolidated Business, results of operations or financial condition of the AG Companies,
taken as a whole, or (ii) prevents the completion of the Acquisition; provided, however, that the term “Material Adverse Effect” excludes any such result to the extent that it is attributable to or results from (a) changes
in general or regional economic conditions; (b) changes generally affecting the industry or region in which any of the AG Companies operates; (c) the identity of Purchaser, including perceived effects of the Contemplated Transactions on
current or prospective customers or revenues of any of the AG Companies, and the cancellation of business commitments or a reduction in the customary or anticipated business commitments are attributable to the identity of Purchaser or its business
practices; (d) actions taken by Purchaser, including the effects of competition between Purchaser and the AG Companies or the breach by Purchaser of its obligations under this Agreement; (e) any act of terrorism or war (whether or not
declared), wherever occurring, any subsequent terrorist, military, diplomatic or political action (other than an act expressly directed at any of the AG Companies); or (f) compliance by any of the AG Companies with the WARN Act with respect to
the Contemplated Transactions. 
 Material Contract is defined in Section 4.11(a). 
 Material IP Rights is defined in Section 4.10. 
  

 A-5 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Material Leases is defined in Section 4.08(b). 
 Material Permits is defined in Section 4.13. 
 Mortgage is defined in Section 4.08(c). 
 National Priorities List is defined in
Section 4.20(b). 
 Norfolk Lease is defined in Section 3.01(b). 
 Owned Real Property is defined in Section 4.08(a)(1). 
 Permits is defined in Section 3.01(f). 
 Permitted Exceptions means the following:

 (a) Liens for Taxes, assessments or governmental charges or levies not yet due; 
 (b) Defects or encumbrances arising by, through or under Purchaser; 
 (c) Rights reserved in federal patents or state deeds; 
 (d) Reserved oil and mineral rights; 
 (e) Building, use, fire/safety, Americans with Disabilities Act, land use, zoning, construction, environmental or protected species laws, regulations, codes, requirements and restrictions; 
 (f) Standard printed exceptions that would be contained in an owners extended coverage policy of title insurance of the Real Property;

 (g) As to the Leased Real Property, the Material Leases, Ground Leases and AG-As-Tenant Leases and associated subleases;

 (h) As to the Owned Real Property, the Fee Property Leases and Owned Real Property Leases and associated subleases;

 (i) Security interests in favor of suppliers of goods for which payment has not yet been made in the ordinary course of
business consistent with past practice; 
 (j) As to the Leased Real Property, (i) Liens on the interests of lessors,
sublessors, lessees and sublessees (but not any of the AG Companies as tenant or lessee or sublessee) and (ii) related subordination, non-disturbance, and attornment agreements and estoppel certificates; 
  

 A-6 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 (k) As to the Owned Real Property, (i) Liens on the interests of lessees and
sublessees (but not any of the AG Companies as lessor) and (ii) related subordination, non-disturbance, and attornment agreements and estoppel certificates; 
 (l) All special exceptions shown in the Commitment; and 
 (m) Liens listed in the Company Disclosure Schedule. 
 Person means any general partnership, limited partnership, limited liability company, corporation, joint venture, trust, business trust, Government Agency, cooperative, association, other entity, or individual,
and the heirs, executors, administrators, legal representatives, successors, and assigns of such person as the context may require. 
 Phase I Assessments is defined in Section 7.04(a). 
 Post-Closing Adjustment is defined in Section 3.05(c)(1).

 Pre-Closing Tax Period is defined in Section 4.16(a). 
 Purchase Price is defined in Section 3.05(a). 
 Purchased Assets is defined in Section 3.01. 
 Purchased Working Capital means the
difference, as of a specified date, between (1) the Purchased Assets and Contributed Assets that are current assets (measured in accordance with Section 3.05(d)) and (2) the Assumed Liabilities that are current liabilities (measured
in accordance with Section 3.05(d)) and the liability associated with the Cash Balance Retirement Plan for Employees of Associated Grocers, Inc. Without limiting the foregoing, in calculating Purchased Working Capital, (A) current assets
exclude Excluded Accounts Receivable and (B) current liabilities exclude all Retained Liabilities and all long-term debt (including the short term portion thereof). 
 Purchaser is defined in the introductory paragraph of this Agreement. 
 Purchaser Disclosure
Schedule is defined in the introductory paragraph to Article 5. 
 Purchaser Material Adverse Effect means the result of an event,
occurrence, or condition that, individually or in the aggregate, prevents the completion of the Acquisition. 
 Qualified Retailers
means all retail customers of the AG Companies, with the exception of (a) those customers with a credit rating, using the Company’s credit rating system, [REDACTED] (b) those customers with a credit rating, using the
Company’s credit rating system, [REDACTED] and (c) [REDACTED]  
 Real Property is defined in
Section 4.08(b). 
  

 A-7 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 Representatives is defined in Section 6.08. 
 Reserves means reasonable reserves for estimated losses with respect to the Acquired Receivables calculated in accordance with
Section 3.05(d), but not including any reserves or allowance with respect to items or amounts reflected in the Purchased Working Capital. 
 Retail Store means the [REDACTED] store located in [REDACTED]. 
 Retained Liabilities is defined in
Section 3.04. 
 Seller Benefit Plans is defined in Section 4.17(a). 
 Statement of Closing Reserves is defined in Section 3.05(c)(1). 
 Statement of Closing Purchased Working Capital is defined in Section 3.05(c)(1). 
 Statement of Estimated Closing Purchased Working Capital is defined in Section 3.05(b)(1). 
 Statement of Estimated Closing Reserves is defined in Section 3.05(b)(2). 
 Statement of Post-Closing Adjustment is defined in Section 3.05(c)(1). 
 Subleased Property is defined in Section 4.08(b). 
 Subsidiary is defined in the introductory paragraph of this Agreement. 
 SUPERVALU Litigation
is defined in Section 3.02(i). 
 Superior Proposal is defined in Section 6.09(c). 
 Supply Agreement is defined in Section 8.02(f). 
 Supply Agreement Adjustment is defined in Section 3.05(b)(3). 
 Takeover Proposal is
defined in Section 6.08. 
 Target Purchased Working Capital is [REDACTED]. 
 Target Reserves means [REDACTED]. 
 Tax means (i) any Federal, state, local and foreign taxes, assessments and other governmental charges, duties, impositions and liabilities, including taxes based upon or measured by gross receipts, income, profits, sales, use
and occupation, and value added, ad valorem, transfer, franchise, withholding, payroll, recapture, employment, excise and property 

  

 A-8 

 CONFIDENTIAL TREATMENT REQUESTED: 
 INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH “[REDACTED]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION. 
 taxes, together with all interest, penalties and additions imposed with respect to such amounts, (ii) any
liability for the payment of any amounts of the type described in clause (i) as a result of being a member of an affiliated, consolidated, combined or unitary group for any period, and (iii) any liability for the payment of any amounts of
the type described in clauses (i) or (ii) as a result of any express or implied obligation to indemnify any other Person. 
 Tax
Adjustment is defined in Section 3.08. 
 Tax Returns is defined in Section 4.16(a). 
 Termination Fee is defined in Section 9.03. 
 Violation means, with respect to Governing Documents, Contracts, or applicable Law to which a Person is party or by which such Person is bound, a violation of or default thereunder (with or without notice or
lapse of time, or both) or which gives rise to a right of termination, cancellation, modification or acceleration of any obligation or loss of any benefit thereunder. 
 WARN Act is defined in Section 4.28. 
 WBCA is defined in Section 6.04. 

Withdrawal Liability is defined in Section 7.03(d). 
 Withdrawal Liability Amount is defined in Section 7.03(d). 
  

 A-9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}]]